{"20251127_173350": {"success": true, "analysis_timestamp": "2025-11-27T17:33:52.022143", "document_info": {"filename": "20251127_173350_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "SaaS", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "SaaS", "fundingStage": "seed"}, "analysis_id": "20251127_173350", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}, "20251127_173352": {"success": true, "analysis_timestamp": "2025-11-27T17:33:59.275920", "document_info": {"filename": "20251127_173352_NVCA-Model-SPA-10-28-2025.docx", "page_count": 18, "word_count": 19265}, "clauses": [{"id": 1, "type": "Board Control", "text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "full_text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "position": 2450, "entities": [{"text": "Purchasers", "label": "ORG", "start": 286, "end": 296}, {"text": "more than one", "label": "CARDINAL", "start": 402, "end": 415}, {"text": "Initial Closing", "label": "ORG", "start": 530, "end": 545}, {"text": "Shares", "label": "ORG", "start": 587, "end": 593}, {"text": "Company", "label": "ORG", "start": 766, "end": 773}, {"text": "Purchasers", "label": "ORG", "start": 782, "end": 792}, {"text": "Initial Closing", "label": "ORG", "start": 908, "end": 923}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 970, "end": 992}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1042, "end": 1053}, {"text": "Purchaser", "label": "ORG", "start": 1126, "end": 1135}, {"text": "the Initial Closing", "label": "ORG", "start": 1237, "end": 1256}, {"text": "Company", "label": "ORG", "start": 1286, "end": 1293}, {"text": "the \u201cAdditional Shares", "label": "ORG", "start": 1611, "end": 1633}, {"text": "one", "label": "CARDINAL", "start": 1640, "end": 1643}, {"text": "Purchasers", "label": "ORG", "start": 1719, "end": 1729}, {"text": "Closings", "label": "PERSON", "start": 1810, "end": 1818}, {"text": "Additional Purchaser", "label": "ORG", "start": 1877, "end": 1897}, {"text": "the Right of First Refus", "label": "ORG", "start": 1976, "end": 2000}], "key_terms": ["1.3", "1.2"], "title": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "General Clause", "text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "position": 5700, "entities": [{"text": "the Tranche Closing Date", "label": "ORG", "start": 48, "end": 72}, {"text": "Purchaser", "label": "ORG", "start": 153, "end": 162}, {"text": "Company", "label": "ORG", "start": 207, "end": 214}, {"text": "Purchaser\u2019s Tranche Closing Shares", "label": "ORG", "start": 221, "end": 255}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 331, "end": 353}, {"text": "Purchaser", "label": "ORG", "start": 372, "end": 381}, {"text": "Elective Closings", "label": "ORG", "start": 424, "end": 441}, {"text": "Purchaser", "label": "ORG", "start": 448, "end": 457}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 526, "end": 548}, {"text": "the Tranche Closing", "label": "ORG", "start": 570, "end": 589}], "key_terms": ["1.2"], "title": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 3, "type": "Pro-Rata Rights", "text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "full_text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "position": 6341, "entities": [{"text": "3", "label": "CARDINAL", "start": 124, "end": 125}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 242, "end": 264}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 483, "end": 505}, {"text": "Purchaser", "label": "ORG", "start": 514, "end": 523}, {"text": "Elective Closing", "label": "ORG", "start": 530, "end": 546}, {"text": "Purchaser", "label": "ORG", "start": 581, "end": 590}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 620, "end": 642}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 741, "end": 763}, {"text": "Purchaser", "label": "ORG", "start": 782, "end": 791}, {"text": "Elective Closing", "label": "PERSON", "start": 799, "end": 815}, {"text": "Tranche Shares", "label": "ORG", "start": 845, "end": 859}, {"text": "the Tranche Closing", "label": "ORG", "start": 901, "end": 920}, {"text": "five business days", "label": "DATE", "start": 973, "end": 991}, {"text": "the Tranche Closing Date", "label": "ORG", "start": 1002, "end": 1026}, {"text": "Purchaser", "label": "ORG", "start": 1059, "end": 1068}, {"text": "Shortfall Shares", "label": "ORG", "start": 1212, "end": 1228}, {"text": "Shares", "label": "ORG", "start": 1434, "end": 1440}, {"text": "Purchaser", "label": "ORG", "start": 1469, "end": 1478}, {"text": "Shares", "label": "ORG", "start": 1511, "end": 1517}, {"text": "Shortfall Shares", "label": "ORG", "start": 1577, "end": 1593}, {"text": "5", "label": "CARDINAL", "start": 1696, "end": 1697}, {"text": "Company", "label": "ORG", "start": 1723, "end": 1730}, {"text": "the Shortfall Notice", "label": "ORG", "start": 1745, "end": 1765}, {"text": "Shortfall Shares", "label": "ORG", "start": 1821, "end": 1837}, {"text": "Complying Purchaser e", "label": "ORG", "start": 1979, "end": 2000}], "key_terms": ["20", "3", "1.2", "5", "15"], "title": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]", "risk_level": "Low", "confidence": 0.7, "explanation": "Pro-rata rights allow investors to maintain their ownership percentage in future rounds by investing proportionally. This is standard, founder-friendly, and actually beneficial as it ensures committed investors can continue supporting the company.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 4, "type": "Conversion Rights", "text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "full_text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "position": 9855, "entities": [{"text": "the Requisite Purchasers", "label": "ORG", "start": 43, "end": 67}, {"text": "Purchasers", "label": "ORG", "start": 88, "end": 98}, {"text": "Purchaser", "label": "ORG", "start": 107, "end": 116}, {"text": "Purchaser\u2019s Affiliates", "label": "ORG", "start": 137, "end": 159}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 202, "end": 224}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 288, "end": 310}, {"text": "Elective Closing", "label": "PERSON", "start": 328, "end": 344}, {"text": "Purchaser", "label": "ORG", "start": 357, "end": 366}, {"text": "Share", "label": "PERSON", "start": 405, "end": 410}, {"text": "the Tranche Closing", "label": "ORG", "start": 472, "end": 491}, {"text": "Defaulting Purchaser", "label": "PERSON", "start": 596, "end": 616}, {"text": "Company", "label": "ORG", "start": 622, "end": 629}, {"text": "Company", "label": "ORG", "start": 712, "end": 719}, {"text": "0.0001", "label": "MONEY", "start": 737, "end": 743}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 765, "end": 782}, {"text": "one-tenth", "label": "CARDINAL", "start": 801, "end": 810}, {"text": "the Subject Preferred Stock", "label": "ORG", "start": 861, "end": 888}, {"text": "5A.1", "label": "CARDINAL", "start": 968, "end": 972}, {"text": "the Restated Certificate", "label": "ORG", "start": 977, "end": 1001}, {"text": "Common Stock", "label": "ORG", "start": 1279, "end": 1291}, {"text": "Common Stock", "label": "ORG", "start": 1620, "end": 1632}, {"text": "Defaulting Purchaser\u2019s", "label": "PERSON", "start": 1679, "end": 1701}, {"text": "Board", "label": "ORG", "start": 1741, "end": 1746}, {"text": "Board", "label": "ORG", "start": 1785, "end": 1790}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1838, "end": 1849}, {"text": "the Common Stock", "label": "ORG", "start": 1913, "end": 1929}, {"text": "$0.00", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["1", "0.0001", "5", "1.2"], "title": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d).", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "Conversion Rights", "text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "full_text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "position": 12774, "entities": [{"text": "Defaulting Purchaser", "label": "PERSON", "start": 151, "end": 171}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 204, "end": 226}], "key_terms": ["5"], "title": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 6, "type": "General Clause", "text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "full_text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "position": 13187, "entities": [], "key_terms": ["4", "1.2"], "title": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 7, "type": "Conversion Rights", "text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "full_text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "position": 13419, "entities": [{"text": "the Outside Date", "label": "ORG", "start": 123, "end": 139}, {"text": "Common Stock", "label": "ORG", "start": 222, "end": 234}, {"text": "Deemed Liquidation Event", "label": "ORG", "start": 273, "end": 297}, {"text": "the Restated Certificate", "label": "ORG", "start": 313, "end": 337}, {"text": "at least 10", "label": "CARDINAL", "start": 416, "end": 427}, {"text": "Termination Event", "label": "ORG", "start": 471, "end": 488}, {"text": "Purchaser", "label": "ORG", "start": 504, "end": 513}, {"text": "Elective Closing", "label": "ORG", "start": 531, "end": 547}, {"text": "Termination Event", "label": "ORG", "start": 562, "end": 579}, {"text": "Purchaser", "label": "ORG", "start": 657, "end": 666}, {"text": "Shares", "label": "ORG", "start": 698, "end": 704}, {"text": "Purchaser", "label": "ORG", "start": 729, "end": 738}, {"text": "Closing", "label": "PERSON", "start": 747, "end": 754}, {"text": "Company", "label": "ORG", "start": 826, "end": 833}, {"text": "Company", "label": "ORG", "start": 888, "end": 895}, {"text": "Company", "label": "ORG", "start": 1277, "end": 1284}, {"text": "the \u201cConvertible Securities", "label": "ORG", "start": 1472, "end": 1499}, {"text": "all Convertible Securities", "label": "ORG", "start": 1564, "end": 1590}, {"text": "Purchaser", "label": "ORG", "start": 1604, "end": 1613}, {"text": "Exhibit", "label": "PERSON", "start": 1630, "end": 1637}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1844, "end": 1855}, {"text": "Exhibit", "label": "PERSON", "start": 1864, "end": 1871}, {"text": "Purchaser\u2019s Convertible Securities", "label": "ORG", "start": 1912, "end": 1946}], "key_terms": ["10", "9", "1.2", "8"], "title": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1", "1.3", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 9, "type": "General Clause", "text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "full_text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "position": 21034, "entities": [{"text": "Company", "label": "ORG", "start": 89, "end": 96}], "key_terms": ["2"], "title": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1", "1933", "2.8"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 11, "type": "Board Control", "text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "full_text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "position": 22607, "entities": [{"text": "Tranche Closing Condition", "label": "ORG", "start": 51, "end": 76}, {"text": "the Board of Directors", "label": "ORG", "start": 140, "end": 162}, {"text": "the Preferred Directors", "label": "ORG", "start": 230, "end": 253}, {"text": "the Restated Certificate", "label": "ORG", "start": 269, "end": 293}, {"text": "the Requisite Purchasers", "label": "ORG", "start": 450, "end": 474}, {"text": "Purchasers", "label": "PERSON", "start": 522, "end": 532}, {"text": "Tranche Closing Date", "label": "ORG", "start": 561, "end": 581}, {"text": "20", "label": "CARDINAL", "start": 659, "end": 661}, {"text": "the Tranche Closing Notice", "label": "ORG", "start": 699, "end": 725}, {"text": "the Management Rights Letter[s", "label": "ORG", "start": 827, "end": 857}, {"text": "the Right of First Refusal", "label": "ORG", "start": 860, "end": 886}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 891, "end": 908}, {"text": "Company", "label": "ORG", "start": 1147, "end": 1154}, {"text": "Purchasers", "label": "ORG", "start": 1160, "end": 1170}, {"text": "Company", "label": "ORG", "start": 1209, "end": 1216}, {"text": "the Initial Closing", "label": "ORG", "start": 1242, "end": 1261}, {"text": "Exhibit\u00a0H", "label": "ORG", "start": 1278, "end": 1287}, {"text": "Purchaser", "label": "ORG", "start": 1417, "end": 1426}], "key_terms": ["10", "2.10", "20"], "title": "Section 2.10(a)(iii) of the Disclosure Schedule.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Investor majority board control", "Founders can be outvoted on critical decisions", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": ["majority"]}, {"id": 12, "type": "Representations & Warranties", "text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "full_text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "position": 24486, "entities": [{"text": "2.3", "label": "DATE", "start": 343, "end": 346}, {"text": "2.4", "label": "CARDINAL", "start": 348, "end": 351}, {"text": "2.5", "label": "CARDINAL", "start": 353, "end": 356}, {"text": "2.6", "label": "CARDINAL", "start": 358, "end": 361}, {"text": "2.21", "label": "CARDINAL", "start": 364, "end": 368}, {"text": "2.22", "label": "CARDINAL", "start": 370, "end": 374}, {"text": "2.23", "label": "CARDINAL", "start": 376, "end": 380}, {"text": "2.24", "label": "CARDINAL", "start": 382, "end": 386}], "key_terms": ["2", "2.2", "2.4", "2.3"], "title": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Representations & Warranties clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["1", "2.25"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 16, "type": "Vesting", "text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "position": 29523, "entities": [{"text": "Common Stock", "label": "ORG", "start": 62, "end": 74}, {"text": "monthly", "label": "DATE", "start": 196, "end": 203}, {"text": "four years", "label": "DATE", "start": 210, "end": 220}, {"text": "one-year", "label": "DATE", "start": 228, "end": 236}, {"text": "monthly", "label": "DATE", "start": 271, "end": 278}, {"text": "Company", "label": "ORG", "start": 386, "end": 393}, {"text": "the Company\u2019s Stock Plan", "label": "ORG", "start": 731, "end": 755}, {"text": "the Restated Certificate", "label": "ORG", "start": 1017, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1047, "end": 1054}, {"text": "Company", "label": "ORG", "start": 1153, "end": 1160}, {"text": "Shares", "label": "ORG", "start": 1242, "end": 1248}, {"text": "Company", "label": "ORG", "start": 1298, "end": 1305}, {"text": "Company", "label": "ORG", "start": 1547, "end": 1554}, {"text": "one", "label": "CARDINAL", "start": 1559, "end": 1562}, {"text": "the Board of Directors", "label": "ORG", "start": 1787, "end": 1809}, {"text": "Company", "label": "ORG", "start": 1867, "end": 1874}, {"text": "the Transaction Agreements", "label": "ORG", "start": 1889, "end": 1915}, {"text": "Shares", "label": "ORG", "start": 1934, "end": 1940}, {"text": "the Common Stock", "label": "ORG", "start": 1973, "end": 1989}], "key_terms": ["2.2"], "title": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock.", "risk_level": "Medium", "confidence": 0.7, "explanation": "Standard 4-year vesting with 1-year cliff. Common but limits founder flexibility.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["3", "2.8"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 19, "type": "IP Assignment", "text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "full_text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "position": 48939, "entities": [{"text": "Persons the Company", "label": "ORG", "start": 159, "end": 178}, {"text": "Certain Transactions", "label": "PERSON", "start": 423, "end": 443}, {"text": "Confidential Information Agreements", "label": "ORG", "start": 567, "end": 602}, {"text": "the Board of Directors", "label": "ORG", "start": 678, "end": 700}, {"text": "Company", "label": "ORG", "start": 738, "end": 745}, {"text": "the Company\u2019s Common Stock", "label": "ORG", "start": 812, "end": 838}, {"text": "the Board of Directors", "label": "ORG", "start": 893, "end": 915}, {"text": "Purchasers", "label": "ORG", "start": 950, "end": 960}, {"text": "Company", "label": "ORG", "start": 1105, "end": 1112}, {"text": "Affiliate", "label": "ORG", "start": 1158, "end": 1167}, {"text": "Affiliate", "label": "ORG", "start": 1332, "end": 1341}, {"text": "Affiliate", "label": "ORG", "start": 1715, "end": 1724}, {"text": "Company", "label": "ORG", "start": 1787, "end": 1794}, {"text": "Company", "label": "ORG", "start": 1958, "end": 1965}, {"text": "2%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["20", "2%", "2.10"], "title": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale, compensation. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 20, "type": "General Clause", "text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "full_text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "position": 57010, "entities": [{"text": "2.15", "label": "CARDINAL", "start": 8, "end": 12}, {"text": "Company", "label": "ORG", "start": 416, "end": 423}, {"text": "Company", "label": "ORG", "start": 571, "end": 578}, {"text": "Company", "label": "ORG", "start": 1705, "end": 1712}, {"text": "Company", "label": "ORG", "start": 1918, "end": 1925}], "key_terms": ["2.15"], "title": "Section\u00a02.15.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 24, "type": "General Clause", "text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "full_text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "position": 66488, "entities": [{"text": "Hazardous Substance", "label": "ORG", "start": 144, "end": 163}, {"text": "Hazardous Substances", "label": "ORG", "start": 342, "end": 362}, {"text": "Qualified Small Business Stock\n\n", "label": "ORG", "start": 367, "end": 399}], "key_terms": ["2.22"], "title": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 25, "type": "General Clause", "text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "full_text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "position": 67006, "entities": [{"text": "Company", "label": "ORG", "start": 41, "end": 48}, {"text": "one-year", "label": "DATE", "start": 146, "end": 154}, {"text": "Company", "label": "ORG", "start": 313, "end": 320}, {"text": "$75 million", "label": "MONEY", "start": 471, "end": 482}, {"text": "Purchasers", "label": "ORG", "start": 693, "end": 703}, {"text": "Company", "label": "ORG", "start": 803, "end": 810}, {"text": "Company", "label": "ORG", "start": 956, "end": 963}, {"text": "$75 million", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["3", "4", "1.1202", "1202"], "title": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 26, "type": "Representations & Warranties", "text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "position": 68123, "entities": [{"text": "CFR", "label": "ORG", "start": 65, "end": 68}, {"text": "concern\u201d][\u201csmaller", "label": "PERSON", "start": 94, "end": 112}, {"text": "the Small Business Investment Act", "label": "ORG", "start": 146, "end": 179}, {"text": "1958", "label": "DATE", "start": 183, "end": 187}, {"text": "the \u201cSmall Business Act", "label": "ORG", "start": 201, "end": 224}, {"text": "107.710", "label": "CARDINAL", "start": 331, "end": 338}, {"text": "Purchaser", "label": "ORG", "start": 398, "end": 407}, {"text": "Small Business Investment Company", "label": "ORG", "start": 427, "end": 460}, {"text": "SBA Forms", "label": "ORG", "start": 486, "end": 495}, {"text": "480", "label": "CARDINAL", "start": 496, "end": 499}, {"text": "652", "label": "CARDINAL", "start": 501, "end": 504}, {"text": "1031", "label": "DATE", "start": 509, "end": 513}, {"text": "Company", "label": "ORG", "start": 573, "end": 580}, {"text": "CFR", "label": "ORG", "start": 670, "end": 673}, {"text": "SBIC Purchaser", "label": "PERSON", "start": 710, "end": 724}, {"text": "Company", "label": "ORG", "start": 853, "end": 860}, {"text": "the U.S. Foreign Corrupt Practices Act", "label": "ORG", "start": 1174, "end": 1212}, {"text": "Company", "label": "ORG", "start": 1758, "end": 1765}], "key_terms": ["1958", "13", "121.301", "121.103"], "title": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["1950", "31", "721", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 28, "type": "Board Control", "text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "full_text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "position": 79902, "entities": [{"text": "FDA", "label": "ORG", "start": 271, "end": 274}, {"text": "56", "label": "CARDINAL", "start": 389, "end": 391}, {"text": "Fed", "label": "ORG", "start": 392, "end": 395}, {"text": "Reg", "label": "PERSON", "start": 397, "end": 400}, {"text": "46191", "label": "DATE", "start": 402, "end": 407}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 409, "end": 425}, {"text": "the \u201c", "label": "ORG", "start": 428, "end": 433}, {"text": "FDA Application Integrity Policy", "label": "ORG", "start": 433, "end": 465}, {"text": "FDA", "label": "ORG", "start": 846, "end": 849}, {"text": "FDA", "label": "ORG", "start": 942, "end": 945}, {"text": "the FDA Application Integrity Policy", "label": "ORG", "start": 956, "end": 992}, {"text": "April 24, 2019", "label": "DATE", "start": 1086, "end": 1100}, {"text": "Company", "label": "ORG", "start": 1107, "end": 1114}, {"text": "European Union", "label": "ORG", "start": 1293, "end": 1307}, {"text": "50%", "label": "PERCENT", "start": 1698, "end": 1701}, {"text": "European Union", "label": "ORG", "start": 1862, "end": 1876}, {"text": "the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019", "label": "ORG", "start": 1929, "end": 2000}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["1320", "10", "7", "56", "46191"], "title": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["1933", "11", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 31, "type": "Board Control", "text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "full_text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "position": 92595, "entities": [{"text": "Shares", "label": "PERSON", "start": 208, "end": 214}, {"text": "Shares", "label": "ORG", "start": 330, "end": 336}, {"text": "Shares", "label": "ORG", "start": 621, "end": 627}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 633, "end": 644}, {"text": "Shares", "label": "ORG", "start": 716, "end": 722}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 787, "end": 798}, {"text": "Known Foreign Purchasers on Exhibit A", "label": "ORG", "start": 883, "end": 920}, {"text": "Purchaser", "label": "ORG", "start": 927, "end": 936}, {"text": "DPA", "label": "ORG", "start": 1064, "end": 1067}, {"text": "Purchaser", "label": "ORG", "start": 1073, "end": 1082}, {"text": "Purchaser", "label": "ORG", "start": 1138, "end": 1147}, {"text": "Purchaser", "label": "ORG", "start": 1226, "end": 1235}, {"text": "DPA", "label": "ORG", "start": 1414, "end": 1417}, {"text": "Company", "label": "ORG", "start": 1444, "end": 1451}, {"text": "the Board of Directors", "label": "ORG", "start": 1491, "end": 1513}, {"text": "Company", "label": "ORG", "start": 1550, "end": 1557}, {"text": "the Board of Directors", "label": "ORG", "start": 1614, "end": 1636}, {"text": "Company", "label": "ORG", "start": 1673, "end": 1680}, {"text": "DPA", "label": "ORG", "start": 1818, "end": 1821}, {"text": "DPA", "label": "ORG", "start": 1931, "end": 1934}], "key_terms": ["7701", "30"], "title": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 32, "type": "Board Control", "text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "full_text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "position": 97237, "entities": [{"text": "the Disclosure Schedule", "label": "ORG", "start": 26, "end": 49}, {"text": "Closing", "label": "PERSON", "start": 148, "end": 155}, {"text": "Closing", "label": "PERSON", "start": 507, "end": 514}, {"text": "Purchasers", "label": "ORG", "start": 684, "end": 694}, {"text": "4.1", "label": "CARDINAL", "start": 798, "end": 801}, {"text": "4.2", "label": "CARDINAL", "start": 806, "end": 809}, {"text": "Shares", "label": "ORG", "start": 1210, "end": 1216}, {"text": "Opinion of Company Counsel", "label": "ORG", "start": 1308, "end": 1334}, {"text": "Purchasers", "label": "ORG", "start": 1342, "end": 1352}, {"text": "Company", "label": "ORG", "start": 1409, "end": 1416}, {"text": "Exhibit", "label": "PERSON", "start": 1494, "end": 1501}, {"text": "Board of Directors", "label": "ORG", "start": 1535, "end": 1553}, {"text": "the Board of Directors", "label": "ORG", "start": 1609, "end": 1631}, {"text": "the Board of Directors", "label": "ORG", "start": 1655, "end": 1677}, {"text": "Purchaser", "label": "ORG", "start": 1883, "end": 1892}, {"text": "Purchaser", "label": "ORG", "start": 1962, "end": 1971}], "key_terms": ["652", "2", "480", "4.1", "4.2"], "title": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 33, "type": "Representations & Warranties", "text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "full_text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "position": 102262, "entities": [{"text": "Shares", "label": "ORG", "start": 592, "end": 598}, {"text": "Co-Sale Agreement\n\n", "label": "ORG", "start": 819, "end": 838}, {"text": "Purchaser", "label": "ORG", "start": 845, "end": 854}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 987, "end": 1004}, {"text": "Purchaser", "label": "ORG", "start": 1032, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1419, "end": 1426}, {"text": "Purchasers", "label": "ORG", "start": 1435, "end": 1445}, {"text": "Purchasers", "label": "ORG", "start": 1693, "end": 1703}, {"text": "Assigns", "label": "PERSON", "start": 1736, "end": 1743}], "key_terms": ["3", "2000"], "title": "Section 3 shall be true and correct in all respects as of the applicable Closing.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "1", "30", "25100", "25102"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 38, "type": "Representations & Warranties", "text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "full_text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "position": 122831, "entities": [{"text": "Purchasers", "label": "ORG", "start": 156, "end": 166}, {"text": "Exhibit", "label": "PERSON", "start": 177, "end": 184}, {"text": "Agreement", "label": "ORG", "start": 297, "end": 306}, {"text": "Agreement", "label": "ORG", "start": 440, "end": 449}, {"text": "1", "label": "CARDINAL", "start": 962, "end": 963}, {"text": "2", "label": "CARDINAL", "start": 1068, "end": 1069}, {"text": "3", "label": "CARDINAL", "start": 1172, "end": 1173}, {"text": "Agreement", "label": "ORG", "start": 1252, "end": 1261}, {"text": "4", "label": "CARDINAL", "start": 1305, "end": 1306}, {"text": "Purchasers", "label": "ORG", "start": 1717, "end": 1727}, {"text": "Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION", "label": "ORG", "start": 1900, "end": 1966}, {"text": "Address of Pur", "label": "ORG", "start": 1986, "end": 2000}, {"text": "Company name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2", "1", "4", "3"], "title": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}], "risk_assessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1", "1933", "2.8"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["1", "2.25"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["1950", "31", "721", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1", "1.3", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["3", "2.8"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "1", "30", "25100", "25102"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["1933", "11", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "riskAssessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1", "1933", "2.8"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["1", "2.25"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["1950", "31", "721", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1", "1.3", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["3", "2.8"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "1", "30", "25100", "25102"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["1933", "11", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 54% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 54% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 8, "priority": "Critical", "clause": "IP Assignment (5 instances found)", "clause_snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby a", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "issue": "Overly broad IP assignment covering all intellectual property", "recommendation": "Add carve-outs for: (1) prior inventions, (2) side projects, (3) unrelated work", "negotiation_tips": ["Document what IP you're bringing to company vs creating for company", "Standard practice is to only assign IP created as part of employment/founder duties", "Offer detailed schedule of excluded IP to provide clarity and avoid future disputes", "Add provision allowing side projects in different fields with prior board approval"], "expected_impact": "Preserves ability to use prior work in future ventures if this startup fails", "risk_level": "High", "specific_concerns": ["Limits ability to work on other projects", "Prior work may be claimed by company"], "detected_terms": ["all intellectual property"], "instances": [{"id": 8, "snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchas"}, {"id": 18, "snippet": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with,"}, {"id": 35, "snippet": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as "}, {"id": 37, "snippet": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUAL"}, {"id": 19, "snippet": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (i"}]}, {"id": 10, "priority": "Critical", "clause": "Board Control (11 instances found)", "clause_snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse ef", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "issue": "This Board Control requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Frame as risk mitigation for investor - founder-led companies perform better statistically", "Propose independent directors with relevant industry expertise as compromise", "Include founder-approval requirements (supermajority) for critical decisions like CEO removal, sale, or IP", "Show examples of successful companies that maintained founder board control"], "expected_impact": "Maintains strategic control and prevents forced exits or CEO replacement", "risk_level": "High", "specific_concerns": [], "detected_terms": ["majority"], "instances": [{"id": 10, "snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially th"}, {"id": 13, "snippet": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Cor"}, {"id": 14, "snippet": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares "}, {"id": 21, "snippet": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other p"}, {"id": 22, "snippet": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Com"}, {"id": 23, "snippet": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, lic"}, {"id": 1, "snippet": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur bet"}, {"id": 11, "snippet": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board "}, {"id": 28, "snippet": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, t"}, {"id": 31, "snippet": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdicti"}, {"id": 32, "snippet": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Cl"}]}, {"id": 15, "priority": "Critical", "clause": "Conversion Rights (5 instances found)", "clause_snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to ", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "issue": "This Conversion Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 15, "snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including t"}, {"id": 29, "snippet": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have n"}, {"id": 4, "snippet": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s A"}, {"id": 5, "snippet": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any"}, {"id": 7, "snippet": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the "}]}, {"id": 17, "priority": "Critical", "clause": "Voting Rights (4 instances found)", "clause_snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in acco", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 17, "snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable fed"}, {"id": 27, "snippet": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operatio"}, {"id": 34, "snippet": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Addres"}, {"id": 36, "snippet": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each futur"}]}, {"id": 26, "priority": "Critical", "clause": "Representations & Warranties (4 instances found)", "clause_snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 o", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "issue": "This Representations & Warranties requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 26, "snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the "}, {"id": 12, "snippet": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readi"}, {"id": 33, "snippet": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing sha"}, {"id": 38, "snippet": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) an"}]}, {"id": 30, "priority": "Critical", "clause": "Liquidation Preference", "clause_snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "issue": "This Liquidation Preference requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Show comparables from similar deals in your sector - 1x non-participating is market standard", "Explain that participating preference misaligns incentives - investors profit even from mediocre exits", "Offer to accept 1.5x non-participating as compromise if investor strongly resists", "Calculate and show investor how participating preference reduces their upside in successful exits"], "expected_impact": "Could increase founder payout by $2-5M in typical exit scenarios", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 30, "snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Compan"}]}, {"id": 2, "priority": "High", "clause": "General Clause (6 instances found)", "clause_snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be update", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Review comparable agreements to identify optimization opportunities", "Focus negotiation energy on higher-priority issues first", "If investor resists, may be acceptable to proceed as-is"], "expected_impact": "Marginal improvement in terms", "risk_level": "Medium", "specific_concerns": [], "detected_terms": ["at any time"], "instances": [{"id": 2, "snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to ea"}, {"id": 6, "snippet": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the c"}, {"id": 9, "snippet": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge"}, {"id": 20, "snippet": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants"}, {"id": 24, "snippet": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazard"}, {"id": 25, "snippet": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-"}]}, {"id": 16, "priority": "High", "clause": "Vesting", "clause_snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "issue": "This Vesting requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Request at least 25% immediate acceleration on acquisition", "Add acceleration if title, role, or compensation changes post-acquisition", "Include that vesting continues during short-term disability"], "expected_impact": "Provides protection worth $200K-$1M in acquisition scenarios", "risk_level": "Medium", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 16, "snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary "}]}], "startup_type": "SaaS", "summary": {"total": 38, "high": 18, "medium": 19, "low": 1}, "metadata": {"startupType": "SaaS", "fundingStage": "seed"}, "analysis_id": "20251127_173352", "filename": "NVCA-Model-SPA-10-28-2025.docx"}, "20251127_174850": {"success": true, "analysis_timestamp": "2025-11-27T17:48:52.568820", "document_info": {"filename": "20251127_174850_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "fintech", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "fintech", "fundingStage": "seed"}, "analysis_id": "20251127_174850", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}, "20251127_175938": {"success": true, "analysis_timestamp": "2025-11-27T17:59:40.520041", "document_info": {"filename": "20251127_175938_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "fintech", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "fintech", "fundingStage": "seed"}, "analysis_id": "20251127_175938", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}, "20251202_030129": {"success": true, "analysis_timestamp": "2025-12-02T03:01:34.607694", "document_info": {"filename": "20251202_030129_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "fintech", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "fintech", "fundingStage": "seed"}, "analysis_id": "20251202_030129", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}, "20251202_030828": {"success": true, "analysis_timestamp": "2025-12-02T03:08:40.952354", "document_info": {"filename": "20251202_030828_NVCA-Model-SPA-10-28-2025.docx", "page_count": 18, "word_count": 19265}, "clauses": [{"id": 1, "type": "Board Control", "text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "full_text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "position": 2450, "entities": [{"text": "Purchasers", "label": "ORG", "start": 286, "end": 296}, {"text": "more than one", "label": "CARDINAL", "start": 402, "end": 415}, {"text": "Initial Closing", "label": "ORG", "start": 530, "end": 545}, {"text": "Shares", "label": "ORG", "start": 587, "end": 593}, {"text": "Company", "label": "ORG", "start": 766, "end": 773}, {"text": "Purchasers", "label": "ORG", "start": 782, "end": 792}, {"text": "Initial Closing", "label": "ORG", "start": 908, "end": 923}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 970, "end": 992}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1042, "end": 1053}, {"text": "Purchaser", "label": "ORG", "start": 1126, "end": 1135}, {"text": "the Initial Closing", "label": "ORG", "start": 1237, "end": 1256}, {"text": "Company", "label": "ORG", "start": 1286, "end": 1293}, {"text": "the \u201cAdditional Shares", "label": "ORG", "start": 1611, "end": 1633}, {"text": "one", "label": "CARDINAL", "start": 1640, "end": 1643}, {"text": "Purchasers", "label": "ORG", "start": 1719, "end": 1729}, {"text": "Closings", "label": "PERSON", "start": 1810, "end": 1818}, {"text": "Additional Purchaser", "label": "ORG", "start": 1877, "end": 1897}, {"text": "the Right of First Refus", "label": "ORG", "start": 1976, "end": 2000}], "key_terms": ["1.3", "1.2"], "title": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "General Clause", "text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "position": 5700, "entities": [{"text": "the Tranche Closing Date", "label": "ORG", "start": 48, "end": 72}, {"text": "Purchaser", "label": "ORG", "start": 153, "end": 162}, {"text": "Company", "label": "ORG", "start": 207, "end": 214}, {"text": "Purchaser\u2019s Tranche Closing Shares", "label": "ORG", "start": 221, "end": 255}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 331, "end": 353}, {"text": "Purchaser", "label": "ORG", "start": 372, "end": 381}, {"text": "Elective Closings", "label": "ORG", "start": 424, "end": 441}, {"text": "Purchaser", "label": "ORG", "start": 448, "end": 457}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 526, "end": 548}, {"text": "the Tranche Closing", "label": "ORG", "start": 570, "end": 589}], "key_terms": ["1.2"], "title": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 3, "type": "Pro-Rata Rights", "text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "full_text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "position": 6341, "entities": [{"text": "3", "label": "CARDINAL", "start": 124, "end": 125}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 242, "end": 264}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 483, "end": 505}, {"text": "Purchaser", "label": "ORG", "start": 514, "end": 523}, {"text": "Elective Closing", "label": "ORG", "start": 530, "end": 546}, {"text": "Purchaser", "label": "ORG", "start": 581, "end": 590}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 620, "end": 642}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 741, "end": 763}, {"text": "Purchaser", "label": "ORG", "start": 782, "end": 791}, {"text": "Elective Closing", "label": "PERSON", "start": 799, "end": 815}, {"text": "Tranche Shares", "label": "ORG", "start": 845, "end": 859}, {"text": "the Tranche Closing", "label": "ORG", "start": 901, "end": 920}, {"text": "five business days", "label": "DATE", "start": 973, "end": 991}, {"text": "the Tranche Closing Date", "label": "ORG", "start": 1002, "end": 1026}, {"text": "Purchaser", "label": "ORG", "start": 1059, "end": 1068}, {"text": "Shortfall Shares", "label": "ORG", "start": 1212, "end": 1228}, {"text": "Shares", "label": "ORG", "start": 1434, "end": 1440}, {"text": "Purchaser", "label": "ORG", "start": 1469, "end": 1478}, {"text": "Shares", "label": "ORG", "start": 1511, "end": 1517}, {"text": "Shortfall Shares", "label": "ORG", "start": 1577, "end": 1593}, {"text": "5", "label": "CARDINAL", "start": 1696, "end": 1697}, {"text": "Company", "label": "ORG", "start": 1723, "end": 1730}, {"text": "the Shortfall Notice", "label": "ORG", "start": 1745, "end": 1765}, {"text": "Shortfall Shares", "label": "ORG", "start": 1821, "end": 1837}, {"text": "Complying Purchaser e", "label": "ORG", "start": 1979, "end": 2000}], "key_terms": ["1.2", "15", "5", "20", "3"], "title": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]", "risk_level": "Low", "confidence": 0.7, "explanation": "Pro-rata rights allow investors to maintain their ownership percentage in future rounds by investing proportionally. This is standard, founder-friendly, and actually beneficial as it ensures committed investors can continue supporting the company.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 4, "type": "Conversion Rights", "text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "full_text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "position": 9855, "entities": [{"text": "the Requisite Purchasers", "label": "ORG", "start": 43, "end": 67}, {"text": "Purchasers", "label": "ORG", "start": 88, "end": 98}, {"text": "Purchaser", "label": "ORG", "start": 107, "end": 116}, {"text": "Purchaser\u2019s Affiliates", "label": "ORG", "start": 137, "end": 159}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 202, "end": 224}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 288, "end": 310}, {"text": "Elective Closing", "label": "PERSON", "start": 328, "end": 344}, {"text": "Purchaser", "label": "ORG", "start": 357, "end": 366}, {"text": "Share", "label": "PERSON", "start": 405, "end": 410}, {"text": "the Tranche Closing", "label": "ORG", "start": 472, "end": 491}, {"text": "Defaulting Purchaser", "label": "PERSON", "start": 596, "end": 616}, {"text": "Company", "label": "ORG", "start": 622, "end": 629}, {"text": "Company", "label": "ORG", "start": 712, "end": 719}, {"text": "0.0001", "label": "MONEY", "start": 737, "end": 743}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 765, "end": 782}, {"text": "one-tenth", "label": "CARDINAL", "start": 801, "end": 810}, {"text": "the Subject Preferred Stock", "label": "ORG", "start": 861, "end": 888}, {"text": "5A.1", "label": "CARDINAL", "start": 968, "end": 972}, {"text": "the Restated Certificate", "label": "ORG", "start": 977, "end": 1001}, {"text": "Common Stock", "label": "ORG", "start": 1279, "end": 1291}, {"text": "Common Stock", "label": "ORG", "start": 1620, "end": 1632}, {"text": "Defaulting Purchaser\u2019s", "label": "PERSON", "start": 1679, "end": 1701}, {"text": "Board", "label": "ORG", "start": 1741, "end": 1746}, {"text": "Board", "label": "ORG", "start": 1785, "end": 1790}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1838, "end": 1849}, {"text": "the Common Stock", "label": "ORG", "start": 1913, "end": 1929}, {"text": "$0.00", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["0.0001", "5", "1", "1.2"], "title": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d).", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "Conversion Rights", "text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "full_text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "position": 12774, "entities": [{"text": "Defaulting Purchaser", "label": "PERSON", "start": 151, "end": 171}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 204, "end": 226}], "key_terms": ["5"], "title": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 6, "type": "General Clause", "text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "full_text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "position": 13187, "entities": [], "key_terms": ["4", "1.2"], "title": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 7, "type": "Conversion Rights", "text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "full_text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "position": 13419, "entities": [{"text": "the Outside Date", "label": "ORG", "start": 123, "end": 139}, {"text": "Common Stock", "label": "ORG", "start": 222, "end": 234}, {"text": "Deemed Liquidation Event", "label": "ORG", "start": 273, "end": 297}, {"text": "the Restated Certificate", "label": "ORG", "start": 313, "end": 337}, {"text": "at least 10", "label": "CARDINAL", "start": 416, "end": 427}, {"text": "Termination Event", "label": "ORG", "start": 471, "end": 488}, {"text": "Purchaser", "label": "ORG", "start": 504, "end": 513}, {"text": "Elective Closing", "label": "ORG", "start": 531, "end": 547}, {"text": "Termination Event", "label": "ORG", "start": 562, "end": 579}, {"text": "Purchaser", "label": "ORG", "start": 657, "end": 666}, {"text": "Shares", "label": "ORG", "start": 698, "end": 704}, {"text": "Purchaser", "label": "ORG", "start": 729, "end": 738}, {"text": "Closing", "label": "PERSON", "start": 747, "end": 754}, {"text": "Company", "label": "ORG", "start": 826, "end": 833}, {"text": "Company", "label": "ORG", "start": 888, "end": 895}, {"text": "Company", "label": "ORG", "start": 1277, "end": 1284}, {"text": "the \u201cConvertible Securities", "label": "ORG", "start": 1472, "end": 1499}, {"text": "all Convertible Securities", "label": "ORG", "start": 1564, "end": 1590}, {"text": "Purchaser", "label": "ORG", "start": 1604, "end": 1613}, {"text": "Exhibit", "label": "PERSON", "start": 1630, "end": 1637}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1844, "end": 1855}, {"text": "Exhibit", "label": "PERSON", "start": 1864, "end": 1871}, {"text": "Purchaser\u2019s Convertible Securities", "label": "ORG", "start": 1912, "end": 1946}], "key_terms": ["10", "8", "9", "1.2"], "title": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1.3", "1", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 9, "type": "General Clause", "text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "full_text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "position": 21034, "entities": [{"text": "Company", "label": "ORG", "start": 89, "end": 96}], "key_terms": ["2"], "title": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1933", "2.8", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 11, "type": "Board Control", "text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "full_text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "position": 22607, "entities": [{"text": "Tranche Closing Condition", "label": "ORG", "start": 51, "end": 76}, {"text": "the Board of Directors", "label": "ORG", "start": 140, "end": 162}, {"text": "the Preferred Directors", "label": "ORG", "start": 230, "end": 253}, {"text": "the Restated Certificate", "label": "ORG", "start": 269, "end": 293}, {"text": "the Requisite Purchasers", "label": "ORG", "start": 450, "end": 474}, {"text": "Purchasers", "label": "PERSON", "start": 522, "end": 532}, {"text": "Tranche Closing Date", "label": "ORG", "start": 561, "end": 581}, {"text": "20", "label": "CARDINAL", "start": 659, "end": 661}, {"text": "the Tranche Closing Notice", "label": "ORG", "start": 699, "end": 725}, {"text": "the Management Rights Letter[s", "label": "ORG", "start": 827, "end": 857}, {"text": "the Right of First Refusal", "label": "ORG", "start": 860, "end": 886}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 891, "end": 908}, {"text": "Company", "label": "ORG", "start": 1147, "end": 1154}, {"text": "Purchasers", "label": "ORG", "start": 1160, "end": 1170}, {"text": "Company", "label": "ORG", "start": 1209, "end": 1216}, {"text": "the Initial Closing", "label": "ORG", "start": 1242, "end": 1261}, {"text": "Exhibit\u00a0H", "label": "ORG", "start": 1278, "end": 1287}, {"text": "Purchaser", "label": "ORG", "start": 1417, "end": 1426}], "key_terms": ["2.10", "20", "10"], "title": "Section 2.10(a)(iii) of the Disclosure Schedule.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Investor majority board control", "Founders can be outvoted on critical decisions", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": ["majority"]}, {"id": 12, "type": "Representations & Warranties", "text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "full_text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "position": 24486, "entities": [{"text": "2.3", "label": "DATE", "start": 343, "end": 346}, {"text": "2.4", "label": "CARDINAL", "start": 348, "end": 351}, {"text": "2.5", "label": "CARDINAL", "start": 353, "end": 356}, {"text": "2.6", "label": "CARDINAL", "start": 358, "end": 361}, {"text": "2.21", "label": "CARDINAL", "start": 364, "end": 368}, {"text": "2.22", "label": "CARDINAL", "start": 370, "end": 374}, {"text": "2.23", "label": "CARDINAL", "start": 376, "end": 380}, {"text": "2.24", "label": "CARDINAL", "start": 382, "end": 386}], "key_terms": ["2", "2.4", "2.3", "2.2"], "title": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Representations & Warranties clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["4", "2.2"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 16, "type": "Vesting", "text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "position": 29523, "entities": [{"text": "Common Stock", "label": "ORG", "start": 62, "end": 74}, {"text": "monthly", "label": "DATE", "start": 196, "end": 203}, {"text": "four years", "label": "DATE", "start": 210, "end": 220}, {"text": "one-year", "label": "DATE", "start": 228, "end": 236}, {"text": "monthly", "label": "DATE", "start": 271, "end": 278}, {"text": "Company", "label": "ORG", "start": 386, "end": 393}, {"text": "the Company\u2019s Stock Plan", "label": "ORG", "start": 731, "end": 755}, {"text": "the Restated Certificate", "label": "ORG", "start": 1017, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1047, "end": 1054}, {"text": "Company", "label": "ORG", "start": 1153, "end": 1160}, {"text": "Shares", "label": "ORG", "start": 1242, "end": 1248}, {"text": "Company", "label": "ORG", "start": 1298, "end": 1305}, {"text": "Company", "label": "ORG", "start": 1547, "end": 1554}, {"text": "one", "label": "CARDINAL", "start": 1559, "end": 1562}, {"text": "the Board of Directors", "label": "ORG", "start": 1787, "end": 1809}, {"text": "Company", "label": "ORG", "start": 1867, "end": 1874}, {"text": "the Transaction Agreements", "label": "ORG", "start": 1889, "end": 1915}, {"text": "Shares", "label": "ORG", "start": 1934, "end": 1940}, {"text": "the Common Stock", "label": "ORG", "start": 1973, "end": 1989}], "key_terms": ["2.2"], "title": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock.", "risk_level": "Medium", "confidence": 0.7, "explanation": "Standard 4-year vesting with 1-year cliff. Common but limits founder flexibility.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 19, "type": "IP Assignment", "text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "full_text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "position": 48939, "entities": [{"text": "Persons the Company", "label": "ORG", "start": 159, "end": 178}, {"text": "Certain Transactions", "label": "PERSON", "start": 423, "end": 443}, {"text": "Confidential Information Agreements", "label": "ORG", "start": 567, "end": 602}, {"text": "the Board of Directors", "label": "ORG", "start": 678, "end": 700}, {"text": "Company", "label": "ORG", "start": 738, "end": 745}, {"text": "the Company\u2019s Common Stock", "label": "ORG", "start": 812, "end": 838}, {"text": "the Board of Directors", "label": "ORG", "start": 893, "end": 915}, {"text": "Purchasers", "label": "ORG", "start": 950, "end": 960}, {"text": "Company", "label": "ORG", "start": 1105, "end": 1112}, {"text": "Affiliate", "label": "ORG", "start": 1158, "end": 1167}, {"text": "Affiliate", "label": "ORG", "start": 1332, "end": 1341}, {"text": "Affiliate", "label": "ORG", "start": 1715, "end": 1724}, {"text": "Company", "label": "ORG", "start": 1787, "end": 1794}, {"text": "Company", "label": "ORG", "start": 1958, "end": 1965}, {"text": "2%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["2.10", "20", "2%"], "title": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale, compensation. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 20, "type": "General Clause", "text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "full_text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "position": 57010, "entities": [{"text": "2.15", "label": "CARDINAL", "start": 8, "end": 12}, {"text": "Company", "label": "ORG", "start": 416, "end": 423}, {"text": "Company", "label": "ORG", "start": 571, "end": 578}, {"text": "Company", "label": "ORG", "start": 1705, "end": 1712}, {"text": "Company", "label": "ORG", "start": 1918, "end": 1925}], "key_terms": ["2.15"], "title": "Section\u00a02.15.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "1974", "2.16"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 24, "type": "General Clause", "text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "full_text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "position": 66488, "entities": [{"text": "Hazardous Substance", "label": "ORG", "start": 144, "end": 163}, {"text": "Hazardous Substances", "label": "ORG", "start": 342, "end": 362}, {"text": "Qualified Small Business Stock\n\n", "label": "ORG", "start": 367, "end": 399}], "key_terms": ["2.22"], "title": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 25, "type": "General Clause", "text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "full_text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "position": 67006, "entities": [{"text": "Company", "label": "ORG", "start": 41, "end": 48}, {"text": "one-year", "label": "DATE", "start": 146, "end": 154}, {"text": "Company", "label": "ORG", "start": 313, "end": 320}, {"text": "$75 million", "label": "MONEY", "start": 471, "end": 482}, {"text": "Purchasers", "label": "ORG", "start": 693, "end": 703}, {"text": "Company", "label": "ORG", "start": 803, "end": 810}, {"text": "Company", "label": "ORG", "start": 956, "end": 963}, {"text": "$75 million", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["1.1202", "1202", "4", "3"], "title": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 26, "type": "Representations & Warranties", "text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "position": 68123, "entities": [{"text": "CFR", "label": "ORG", "start": 65, "end": 68}, {"text": "concern\u201d][\u201csmaller", "label": "PERSON", "start": 94, "end": 112}, {"text": "the Small Business Investment Act", "label": "ORG", "start": 146, "end": 179}, {"text": "1958", "label": "DATE", "start": 183, "end": 187}, {"text": "the \u201cSmall Business Act", "label": "ORG", "start": 201, "end": 224}, {"text": "107.710", "label": "CARDINAL", "start": 331, "end": 338}, {"text": "Purchaser", "label": "ORG", "start": 398, "end": 407}, {"text": "Small Business Investment Company", "label": "ORG", "start": 427, "end": 460}, {"text": "SBA Forms", "label": "ORG", "start": 486, "end": 495}, {"text": "480", "label": "CARDINAL", "start": 496, "end": 499}, {"text": "652", "label": "CARDINAL", "start": 501, "end": 504}, {"text": "1031", "label": "DATE", "start": 509, "end": 513}, {"text": "Company", "label": "ORG", "start": 573, "end": 580}, {"text": "CFR", "label": "ORG", "start": 670, "end": 673}, {"text": "SBIC Purchaser", "label": "PERSON", "start": 710, "end": 724}, {"text": "Company", "label": "ORG", "start": 853, "end": 860}, {"text": "the U.S. Foreign Corrupt Practices Act", "label": "ORG", "start": 1174, "end": 1212}, {"text": "Company", "label": "ORG", "start": 1758, "end": 1765}], "key_terms": ["13", "121.301", "121.103", "1958"], "title": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["31", "800", "2", "721", "1950"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 28, "type": "Board Control", "text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "full_text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "position": 79902, "entities": [{"text": "FDA", "label": "ORG", "start": 271, "end": 274}, {"text": "56", "label": "CARDINAL", "start": 389, "end": 391}, {"text": "Fed", "label": "ORG", "start": 392, "end": 395}, {"text": "Reg", "label": "PERSON", "start": 397, "end": 400}, {"text": "46191", "label": "DATE", "start": 402, "end": 407}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 409, "end": 425}, {"text": "the \u201c", "label": "ORG", "start": 428, "end": 433}, {"text": "FDA Application Integrity Policy", "label": "ORG", "start": 433, "end": 465}, {"text": "FDA", "label": "ORG", "start": 846, "end": 849}, {"text": "FDA", "label": "ORG", "start": 942, "end": 945}, {"text": "the FDA Application Integrity Policy", "label": "ORG", "start": 956, "end": 992}, {"text": "April 24, 2019", "label": "DATE", "start": 1086, "end": 1100}, {"text": "Company", "label": "ORG", "start": 1107, "end": 1114}, {"text": "European Union", "label": "ORG", "start": 1293, "end": 1307}, {"text": "50%", "label": "PERCENT", "start": 1698, "end": 1701}, {"text": "European Union", "label": "ORG", "start": 1862, "end": 1876}, {"text": "the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019", "label": "ORG", "start": 1929, "end": 2000}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["56", "10", "46191", "7", "1320"], "title": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["11", "1933", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 31, "type": "Board Control", "text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "full_text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "position": 92595, "entities": [{"text": "Shares", "label": "PERSON", "start": 208, "end": 214}, {"text": "Shares", "label": "ORG", "start": 330, "end": 336}, {"text": "Shares", "label": "ORG", "start": 621, "end": 627}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 633, "end": 644}, {"text": "Shares", "label": "ORG", "start": 716, "end": 722}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 787, "end": 798}, {"text": "Known Foreign Purchasers on Exhibit A", "label": "ORG", "start": 883, "end": 920}, {"text": "Purchaser", "label": "ORG", "start": 927, "end": 936}, {"text": "DPA", "label": "ORG", "start": 1064, "end": 1067}, {"text": "Purchaser", "label": "ORG", "start": 1073, "end": 1082}, {"text": "Purchaser", "label": "ORG", "start": 1138, "end": 1147}, {"text": "Purchaser", "label": "ORG", "start": 1226, "end": 1235}, {"text": "DPA", "label": "ORG", "start": 1414, "end": 1417}, {"text": "Company", "label": "ORG", "start": 1444, "end": 1451}, {"text": "the Board of Directors", "label": "ORG", "start": 1491, "end": 1513}, {"text": "Company", "label": "ORG", "start": 1550, "end": 1557}, {"text": "the Board of Directors", "label": "ORG", "start": 1614, "end": 1636}, {"text": "Company", "label": "ORG", "start": 1673, "end": 1680}, {"text": "DPA", "label": "ORG", "start": 1818, "end": 1821}, {"text": "DPA", "label": "ORG", "start": 1931, "end": 1934}], "key_terms": ["7701", "30"], "title": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 32, "type": "Board Control", "text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "full_text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "position": 97237, "entities": [{"text": "the Disclosure Schedule", "label": "ORG", "start": 26, "end": 49}, {"text": "Closing", "label": "PERSON", "start": 148, "end": 155}, {"text": "Closing", "label": "PERSON", "start": 507, "end": 514}, {"text": "Purchasers", "label": "ORG", "start": 684, "end": 694}, {"text": "4.1", "label": "CARDINAL", "start": 798, "end": 801}, {"text": "4.2", "label": "CARDINAL", "start": 806, "end": 809}, {"text": "Shares", "label": "ORG", "start": 1210, "end": 1216}, {"text": "Opinion of Company Counsel", "label": "ORG", "start": 1308, "end": 1334}, {"text": "Purchasers", "label": "ORG", "start": 1342, "end": 1352}, {"text": "Company", "label": "ORG", "start": 1409, "end": 1416}, {"text": "Exhibit", "label": "PERSON", "start": 1494, "end": 1501}, {"text": "Board of Directors", "label": "ORG", "start": 1535, "end": 1553}, {"text": "the Board of Directors", "label": "ORG", "start": 1609, "end": 1631}, {"text": "the Board of Directors", "label": "ORG", "start": 1655, "end": 1677}, {"text": "Purchaser", "label": "ORG", "start": 1883, "end": 1892}, {"text": "Purchaser", "label": "ORG", "start": 1962, "end": 1971}], "key_terms": ["4.2", "4.1", "652", "480", "2"], "title": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 33, "type": "Representations & Warranties", "text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "full_text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "position": 102262, "entities": [{"text": "Shares", "label": "ORG", "start": 592, "end": 598}, {"text": "Co-Sale Agreement\n\n", "label": "ORG", "start": 819, "end": 838}, {"text": "Purchaser", "label": "ORG", "start": 845, "end": 854}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 987, "end": 1004}, {"text": "Purchaser", "label": "ORG", "start": 1032, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1419, "end": 1426}, {"text": "Purchasers", "label": "ORG", "start": 1435, "end": 1445}, {"text": "Purchasers", "label": "ORG", "start": 1693, "end": 1703}, {"text": "Assigns", "label": "PERSON", "start": 1736, "end": 1743}], "key_terms": ["2000", "3"], "title": "Section 3 shall be true and correct in all respects as of the applicable Closing.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25100", "25105", "25102", "1", "30"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 38, "type": "Representations & Warranties", "text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "full_text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "position": 122831, "entities": [{"text": "Purchasers", "label": "ORG", "start": 156, "end": 166}, {"text": "Exhibit", "label": "PERSON", "start": 177, "end": 184}, {"text": "Agreement", "label": "ORG", "start": 297, "end": 306}, {"text": "Agreement", "label": "ORG", "start": 440, "end": 449}, {"text": "1", "label": "CARDINAL", "start": 962, "end": 963}, {"text": "2", "label": "CARDINAL", "start": 1068, "end": 1069}, {"text": "3", "label": "CARDINAL", "start": 1172, "end": 1173}, {"text": "Agreement", "label": "ORG", "start": 1252, "end": 1261}, {"text": "4", "label": "CARDINAL", "start": 1305, "end": 1306}, {"text": "Purchasers", "label": "ORG", "start": 1717, "end": 1727}, {"text": "Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION", "label": "ORG", "start": 1900, "end": 1966}, {"text": "Address of Pur", "label": "ORG", "start": 1986, "end": 2000}, {"text": "Company name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2", "4", "1", "3"], "title": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}], "risk_assessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1933", "2.8", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "1974", "2.16"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["31", "800", "2", "721", "1950"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1.3", "1", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25100", "25105", "25102", "1", "30"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["4", "2.2"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["11", "1933", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "riskAssessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["1933", "2.8", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "1974", "2.16"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["31", "800", "2", "721", "1950"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1.3", "1", "1986"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25100", "25105", "25102", "1", "30"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["4", "2.2"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["11", "1933", "501"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 54% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 54% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 8, "priority": "Critical", "clause": "IP Assignment (5 instances found)", "clause_snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby a", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "issue": "Overly broad IP assignment covering all intellectual property", "recommendation": "Add carve-outs for: (1) prior inventions, (2) side projects, (3) unrelated work", "negotiation_tips": ["Document what IP you're bringing to company vs creating for company", "Standard practice is to only assign IP created as part of employment/founder duties", "Offer detailed schedule of excluded IP to provide clarity and avoid future disputes", "Add provision allowing side projects in different fields with prior board approval"], "expected_impact": "Preserves ability to use prior work in future ventures if this startup fails", "risk_level": "High", "specific_concerns": ["Limits ability to work on other projects", "Prior work may be claimed by company"], "detected_terms": ["all intellectual property"], "instances": [{"id": 8, "snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchas"}, {"id": 18, "snippet": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with,"}, {"id": 35, "snippet": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as "}, {"id": 37, "snippet": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUAL"}, {"id": 19, "snippet": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (i"}]}, {"id": 10, "priority": "Critical", "clause": "Board Control (11 instances found)", "clause_snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse ef", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "issue": "This Board Control requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Frame as risk mitigation for investor - founder-led companies perform better statistically", "Propose independent directors with relevant industry expertise as compromise", "Include founder-approval requirements (supermajority) for critical decisions like CEO removal, sale, or IP", "Show examples of successful companies that maintained founder board control"], "expected_impact": "Maintains strategic control and prevents forced exits or CEO replacement", "risk_level": "High", "specific_concerns": [], "detected_terms": ["majority"], "instances": [{"id": 10, "snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially th"}, {"id": 13, "snippet": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Cor"}, {"id": 14, "snippet": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares "}, {"id": 21, "snippet": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other p"}, {"id": 22, "snippet": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Com"}, {"id": 23, "snippet": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, lic"}, {"id": 1, "snippet": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur bet"}, {"id": 11, "snippet": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board "}, {"id": 28, "snippet": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, t"}, {"id": 31, "snippet": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdicti"}, {"id": 32, "snippet": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Cl"}]}, {"id": 15, "priority": "Critical", "clause": "Conversion Rights (5 instances found)", "clause_snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to ", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "issue": "This Conversion Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 15, "snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including t"}, {"id": 29, "snippet": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have n"}, {"id": 4, "snippet": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s A"}, {"id": 5, "snippet": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any"}, {"id": 7, "snippet": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the "}]}, {"id": 17, "priority": "Critical", "clause": "Voting Rights (4 instances found)", "clause_snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in acco", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 17, "snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable fed"}, {"id": 27, "snippet": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operatio"}, {"id": 34, "snippet": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Addres"}, {"id": 36, "snippet": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each futur"}]}, {"id": 26, "priority": "Critical", "clause": "Representations & Warranties (4 instances found)", "clause_snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 o", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "issue": "This Representations & Warranties requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 26, "snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the "}, {"id": 12, "snippet": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readi"}, {"id": 33, "snippet": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing sha"}, {"id": 38, "snippet": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) an"}]}, {"id": 30, "priority": "Critical", "clause": "Liquidation Preference", "clause_snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "issue": "This Liquidation Preference requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Show comparables from similar deals in your sector - 1x non-participating is market standard", "Explain that participating preference misaligns incentives - investors profit even from mediocre exits", "Offer to accept 1.5x non-participating as compromise if investor strongly resists", "Calculate and show investor how participating preference reduces their upside in successful exits"], "expected_impact": "Could increase founder payout by $2-5M in typical exit scenarios", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 30, "snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Compan"}]}, {"id": 2, "priority": "High", "clause": "General Clause (6 instances found)", "clause_snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be update", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Review comparable agreements to identify optimization opportunities", "Focus negotiation energy on higher-priority issues first", "If investor resists, may be acceptable to proceed as-is"], "expected_impact": "Marginal improvement in terms", "risk_level": "Medium", "specific_concerns": [], "detected_terms": ["at any time"], "instances": [{"id": 2, "snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to ea"}, {"id": 6, "snippet": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the c"}, {"id": 9, "snippet": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge"}, {"id": 20, "snippet": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants"}, {"id": 24, "snippet": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazard"}, {"id": 25, "snippet": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-"}]}, {"id": 16, "priority": "High", "clause": "Vesting", "clause_snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "issue": "This Vesting requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Request at least 25% immediate acceleration on acquisition", "Add acceleration if title, role, or compensation changes post-acquisition", "Include that vesting continues during short-term disability"], "expected_impact": "Provides protection worth $200K-$1M in acquisition scenarios", "risk_level": "Medium", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 16, "snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary "}]}], "startup_type": "SaaS", "summary": {"total": 38, "high": 18, "medium": 19, "low": 1}, "metadata": {"startupType": "SaaS", "fundingStage": "seed"}, "analysis_id": "20251202_030828", "filename": "NVCA-Model-SPA-10-28-2025.docx"}, "20251202_030855": {"success": true, "analysis_timestamp": "2025-12-02T03:08:58.359885", "document_info": {"filename": "20251202_030855_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from SaaS startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "SaaS", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "SaaS", "fundingStage": "seed"}, "analysis_id": "20251202_030855", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}, "20251202_034346": {"success": true, "analysis_timestamp": "2025-12-02T03:43:57.598930", "document_info": {"filename": "20251202_034346_NVCA-Model-SPA-10-28-2025.docx", "page_count": 18, "word_count": 19265}, "clauses": [{"id": 1, "type": "Board Control", "text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "full_text": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.\n\nClosing[s]; Delivery.\n\n[Initial Closing.] The [initial] purchase and sale of the Shares shall take place remotely via the exchange of documents and signatures, on the date of this Agreement at such time as is mutually agreed upon, orally or in writing, by the Company and the Purchasers (the consummation of such purchase and sale being designated as the \u201c[Initial] Closing\u201d). , [Each Purchaser at the Initial Closing shall be obligated to purchase that number of Tranche Closing Shares (as defined below) as is set forth opposite such Purchaser\u2019s name on Exhibit A under the heading \u201cTranche Closing Shares\u201d (as to any Purchaser, its \u201cTranche Closing Shares\u201d), as provided in Section [1.2(c)] below.]\n\n[Additional Closings. After the Initial Closing and on or before [date], the Company may sell, on the same terms and conditions as those contained in this Agreement, any unsold shares [up to [_________] additional shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or similar recapitalization affecting such shares)] of Series [___] Preferred Stock (the \u201cAdditional Shares\u201d), to one or more purchasers (the \u201cAdditional Purchasers\u201d) [reasonably acceptable to Purchasers holding a [specify percentage] of the then outstanding Shares] in any number of Closings (each an \u201cAdditional Closing\u201d), provided that [(i)]  each Additional Purchaser becomes a party to the Investors\u2019 Rights Agreement, the Voting Agreement, and the Right of First Refusal and Co-Sale Agreement, each as defined below, by executing and delivering a counterpart signature page to each of such Transaction Agreements [and (ii) each Additional Purchaser in an Additional Closing occurring prior to the Tranche Closing shall be obligated to purchase such Purchaser\u2019s Tranche Closing Shares, as provided in Section [1.2(c)] below]. Exhibit\u00a0A to this Agreement shall be updated to reflect [(i)] the number of Additional Shares purchased at each such Closing and the parties purchasing such Additional Shares [and (ii) the number of Tranche Closing Shares, if applicable, required to be purchased by each Additional Purchaser.] \n\n[Tranche Closing. \n\nTranche Closing. If, on or before [date] (the \u201cOutside Date\u201d), the Tranche Closing Condition (as defined below) is satisfied, then (A) the Company shall promptly deliver a written notice to the Purchasers (the \u201cTranche Closing Notice\u201d) confirming the satisfaction of the Tranche Closing Condition and specifying the Tranche Closing Date (as defined below) and (B) each Purchaser that has purchased Shares prior to the Tranche Closing Date shall be obligated to purchase (together with its Affiliates but without duplication) its Tranche Closing Shares (as adjusted pursuant to", "position": 2450, "entities": [{"text": "Purchasers", "label": "ORG", "start": 286, "end": 296}, {"text": "more than one", "label": "CARDINAL", "start": 402, "end": 415}, {"text": "Initial Closing", "label": "ORG", "start": 530, "end": 545}, {"text": "Shares", "label": "ORG", "start": 587, "end": 593}, {"text": "Company", "label": "ORG", "start": 766, "end": 773}, {"text": "Purchasers", "label": "ORG", "start": 782, "end": 792}, {"text": "Initial Closing", "label": "ORG", "start": 908, "end": 923}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 970, "end": 992}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1042, "end": 1053}, {"text": "Purchaser", "label": "ORG", "start": 1126, "end": 1135}, {"text": "the Initial Closing", "label": "ORG", "start": 1237, "end": 1256}, {"text": "Company", "label": "ORG", "start": 1286, "end": 1293}, {"text": "the \u201cAdditional Shares", "label": "ORG", "start": 1611, "end": 1633}, {"text": "one", "label": "CARDINAL", "start": 1640, "end": 1643}, {"text": "Purchasers", "label": "ORG", "start": 1719, "end": 1729}, {"text": "Closings", "label": "PERSON", "start": 1810, "end": 1818}, {"text": "Additional Purchaser", "label": "ORG", "start": 1877, "end": 1897}, {"text": "the Right of First Refus", "label": "ORG", "start": 1976, "end": 2000}], "key_terms": ["1.2", "1.3"], "title": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur between the date of this Agreement and the applicable Closing (as defined below). The shares of Series\u00a0[___] Preferred Stock issued to the Purchasers pursuant to this Agreement shall be referred to in this Agreement as the \u201cShares.\u201d In the event there is more than one closing, the term \u201cClosing\u201d shall apply to each such closing unless otherwise specified.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "General Clause", "text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "position": 5700, "entities": [{"text": "the Tranche Closing Date", "label": "ORG", "start": 48, "end": 72}, {"text": "Purchaser", "label": "ORG", "start": 153, "end": 162}, {"text": "Company", "label": "ORG", "start": 207, "end": 214}, {"text": "Purchaser\u2019s Tranche Closing Shares", "label": "ORG", "start": 221, "end": 255}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 331, "end": 353}, {"text": "Purchaser", "label": "ORG", "start": 372, "end": 381}, {"text": "Elective Closings", "label": "ORG", "start": 424, "end": 441}, {"text": "Purchaser", "label": "ORG", "start": 448, "end": 457}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 526, "end": 548}, {"text": "the Tranche Closing", "label": "ORG", "start": 570, "end": 589}], "key_terms": ["1.2"], "title": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 3, "type": "Pro-Rata Rights", "text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "full_text": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]\n\nShortfall Closing. If any Tranche Shares remain unpurchased immediately following the Tranche Closing (the \u201cShortfall Shares\u201d), the Company shall, within five business days following the Tranche Closing Date, provide written notice to each Purchaser that is not a Defaulting Purchaser (each, a \u201cComplying Purchaser,\u201d and such notice, the \u201cShortfall Notice\u201d), setting forth the total number of Shortfall Shares and the date for the Shortfall Closing (as defined below). Each Complying Purchaser will have the right, but not the obligation, to purchase the Shortfall Shares on a pro rata basis based on the number of Shares then held by such Complying Purchaser compared to the total number of Shares then held by all Complying Purchasers electing to purchase Shortfall Shares at a Closing (a \u201cShortfall Closing\u201d), exercisable by delivering written notice to the Company within [5] business days after the Company\u2019s delivery of the Shortfall Notice, which notice shall also specify the maximum number of Shortfall Shares, if any, such Complying Purchaser wishes to purchase in excess of such Complying Purchaser\u2019s pro rata percentage (the \u201cExcess Amount\u201d) (each Complying Purchaser electing to purchase being referred to herein as a \u201cParticipating Purchaser\u201d). Any Shortfall Shares not elected to be purchased by a Complying Purchaser shall automatically be deemed elected to be purchased by the Participating Purchasers who specified an Excess Amount in their respective notices delivered to the Company, and allocated among such Participating Purchasers in proportion to their respective pro rata percentages; provided, that in no event shall an amount greater than a Participating Purchaser\u2019s Excess Amount be allocated to such Participating Purchaser. The procedure set forth in the preceding sentence shall be applied on an iterative basis until the entire Excess Amount of each Participating Purchaser has been satisfied or until all Shortfall Shares shall have been allocated. In no event shall a Complying Purchaser be deemed to be a Defaulting Purchaser as a result of such Complying Purchaser\u2019s failure to purchase shares at a Shortfall Closing. Any Shortfall Closing shall occur on the date specified in the Shortfall Notice, which date shall be not less than [15] business days after and not more [20] business days after the date on which the Shortfall Notice is delivered to the Complying Purchasers. Exhibit A to this Agreement shall be updated to reflect the number of any Shortfall Shares (if any) purchased by each Purchaser at the Shortfall Closing.\n\n[Special Mandatory Conversion.  \n\nExcept as otherwise specified in this Agreement or the Restated Certificate, and unless this", "position": 6341, "entities": [{"text": "3", "label": "CARDINAL", "start": 124, "end": 125}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 242, "end": 264}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 483, "end": 505}, {"text": "Purchaser", "label": "ORG", "start": 514, "end": 523}, {"text": "Elective Closing", "label": "ORG", "start": 530, "end": 546}, {"text": "Purchaser", "label": "ORG", "start": 581, "end": 590}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 620, "end": 642}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 741, "end": 763}, {"text": "Purchaser", "label": "ORG", "start": 782, "end": 791}, {"text": "Elective Closing", "label": "PERSON", "start": 799, "end": 815}, {"text": "Tranche Shares", "label": "ORG", "start": 845, "end": 859}, {"text": "the Tranche Closing", "label": "ORG", "start": 901, "end": 920}, {"text": "five business days", "label": "DATE", "start": 973, "end": 991}, {"text": "the Tranche Closing Date", "label": "ORG", "start": 1002, "end": 1026}, {"text": "Purchaser", "label": "ORG", "start": 1059, "end": 1068}, {"text": "Shortfall Shares", "label": "ORG", "start": 1212, "end": 1228}, {"text": "Shares", "label": "ORG", "start": 1434, "end": 1440}, {"text": "Purchaser", "label": "ORG", "start": 1469, "end": 1478}, {"text": "Shares", "label": "ORG", "start": 1511, "end": 1517}, {"text": "Shortfall Shares", "label": "ORG", "start": 1577, "end": 1593}, {"text": "5", "label": "CARDINAL", "start": 1696, "end": 1697}, {"text": "Company", "label": "ORG", "start": 1723, "end": 1730}, {"text": "the Shortfall Notice", "label": "ORG", "start": 1745, "end": 1765}, {"text": "Shortfall Shares", "label": "ORG", "start": 1821, "end": 1837}, {"text": "Complying Purchaser e", "label": "ORG", "start": 1979, "end": 2000}], "key_terms": ["1.2", "20", "3", "5", "15"], "title": "Section 1.2(c) (each, an \u201cElective Closing\u201d), subject, in each case, to such Purchaser providing the Company with at least [3] business days\u2019 prior written notice (an \u201cElective Notice\u201d) of the date on which such Purchaser shall purchase such Tranche Closing Shares. Promptly following receipt of any Elective Notice the Company shall provide a copy of such Elective Notice to each other Purchaser that did not submit a substantially concurrent Elective Notice.  Any purchase of such Tranche Closing Shares by such Purchaser at an Elective Closing shall proportionately reduce such Purchaser\u2019s obligation to purchase its Tranche Closing Shares at the Tranche Closing. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at any Elective Closing.]", "risk_level": "Low", "confidence": 0.7, "explanation": "Pro-rata rights allow investors to maintain their ownership percentage in future rounds by investing proportionally. This is standard, founder-friendly, and actually beneficial as it ensures committed investors can continue supporting the company.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 4, "type": "Conversion Rights", "text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "full_text": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d). \n\nUpon a Special Mandatory Conversion, all rights with respect to the Series [___] Preferred Stock converted pursuant to such Special Mandatory Conversion, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate  (notwithstanding the failure of the holder or holders thereof to surrender the certificates for such shares on or prior to such time), except for the rights of the holders thereof, upon surrender of the certificate or certificates therefor, to receive a certificate or certificates for the number of shares of Common Stock issuable on such conversion. In addition, any Defaulting Purchaser\u2019s (i) right to designate a member of the Board and/or an observer to meetings of the Board (if such conversion results in such Defaulting Purchaser\u2019s holdings falling below requisite levels), (ii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, registration rights and rights to purchase future issuances of equity of the Company under the Investors\u2019 Rights Agreement, as defined below, and (iii) with respect to the Common Stock issued pursuant to a Special Mandatory Conversion only, rights of first refusal and co-sale under the Right of First Refusal and Co-Sale Agreement, as defined below, in each case pursuant to any agreement with the Company, shall all automatically terminate upon such conversion, effective upon, subject to, and concurrently with, the consummation of the Tranche Closing. Any Defaulting Purchaser hereby agrees to execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to confirm any of the foregoing as reasonably requested by the Company.\n\nThe Company and the Purchasers agree that the Special Mandatory Conversion provisions of this Agreement and Article Fourth, Part B,", "position": 9855, "entities": [{"text": "the Requisite Purchasers", "label": "ORG", "start": 43, "end": 67}, {"text": "Purchasers", "label": "ORG", "start": 88, "end": 98}, {"text": "Purchaser", "label": "ORG", "start": 107, "end": 116}, {"text": "Purchaser\u2019s Affiliates", "label": "ORG", "start": 137, "end": 159}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 202, "end": 224}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 288, "end": 310}, {"text": "Elective Closing", "label": "PERSON", "start": 328, "end": 344}, {"text": "Purchaser", "label": "ORG", "start": 357, "end": 366}, {"text": "Share", "label": "PERSON", "start": 405, "end": 410}, {"text": "the Tranche Closing", "label": "ORG", "start": 472, "end": 491}, {"text": "Defaulting Purchaser", "label": "PERSON", "start": 596, "end": 616}, {"text": "Company", "label": "ORG", "start": 622, "end": 629}, {"text": "Company", "label": "ORG", "start": 712, "end": 719}, {"text": "0.0001", "label": "MONEY", "start": 737, "end": 743}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 765, "end": 782}, {"text": "one-tenth", "label": "CARDINAL", "start": 801, "end": 810}, {"text": "the Subject Preferred Stock", "label": "ORG", "start": 861, "end": 888}, {"text": "5A.1", "label": "CARDINAL", "start": 968, "end": 972}, {"text": "the Restated Certificate", "label": "ORG", "start": 977, "end": 1001}, {"text": "Common Stock", "label": "ORG", "start": 1279, "end": 1291}, {"text": "Common Stock", "label": "ORG", "start": 1620, "end": 1632}, {"text": "Defaulting Purchaser\u2019s", "label": "PERSON", "start": 1679, "end": 1701}, {"text": "Board", "label": "ORG", "start": 1741, "end": 1746}, {"text": "Board", "label": "ORG", "start": 1785, "end": 1790}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1838, "end": 1849}, {"text": "the Common Stock", "label": "ORG", "start": 1913, "end": 1929}, {"text": "$0.00", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["1.2", "0.0001", "1", "5"], "title": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s Affiliates, fails to purchase its required number of Tranche Closing Shares at the Tranche Closing (including for calculation purposes all Tranche Closing Shares purchased at any Elective Closing)  (any such Purchaser, a \u201cDefaulting Purchaser\u201d), then each Share held by such Defaulting Purchaser as of immediately prior to the Tranche Closing (the \u201cSubject Preferred Stock\u201d) shall automatically, and without any further action on the part of such Defaulting Purchaser, the Company or any other Person, be converted into fully paid and nonassessable shares of the Company\u2019s common stock, $0.0001 par value per share (the \u201cCommon Stock\u201d) at the rate of [one-tenth] of a share of Common Stock for each one share of the Subject Preferred Stock, all pursuant to, and as further provided in, Article Fourth, Part B, Section\u00a0[5A.1] of the Restated Certificate (a \u201cSpecial Mandatory Conversion\u201d).", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "Conversion Rights", "text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "full_text": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.\n\nAs a condition to any transfer of a Purchaser\u2019s Series [___] Preferred Stock (or Common Stock issued upon conversion thereof pursuant to Article Fourth, Part B,", "position": 12774, "entities": [{"text": "Defaulting Purchaser", "label": "PERSON", "start": 151, "end": 171}, {"text": "Tranche Closing Shares", "label": "ORG", "start": 204, "end": 226}], "key_terms": ["5"], "title": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any Defaulting Purchaser for the failure to purchase its Tranche Closing Shares at the Tranche Closing.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 6, "type": "General Clause", "text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "full_text": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2\n\nTermination of", "position": 13187, "entities": [], "key_terms": ["1.2", "4"], "title": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the conditions specified in this Agreement, including this Section 1.2", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 7, "type": "Conversion Rights", "text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "full_text": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]\n\nClosing Deliverables.  At each Closing, the Company shall deliver to each Purchaser a certificate representing the Shares being purchased by such Purchaser at such Closing against payment of the purchase price therefor by check payable to the Company, by wire transfer to a bank account designated by the Company, by cancellation or conversion of indebtedness or other convertible securities of the Company to Purchaser[, including interest], or by any combination of such methods.\n\nConversion and Termination of Convertible Securities.\n\nBy executing and delivering this Agreement, each Purchaser holding one or more [simple agreements for future equity and/or convertible notes] issued by the Company prior to the date of this Agreement (each, regardless of whether held by a Purchaser or not, a \u201cConvertible Security\u201d and, collectively, regardless of whether held by a Purchaser or not, the \u201cConvertible Securities\u201d) hereby irrevocably agrees that:\n\nThe aggregate face amount of all Convertible Securities held by such Purchaser is set forth on Exhibit\u00a0A under the column heading \u201cConvertible Securities\u201d;\n\nSuch Purchaser is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts shown opposite such Purchaser\u2019s name on Exhibit\u00a0A;\n\nAt the Initial Closing, all of such Purchaser\u2019s Convertible Securities will automatically and without any action on the part of such Purchaser convert into the number of shares of Series [___] Preferred Stock set forth opposite such Purchaser\u2019s name under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A (as to any Purchaser, such shares being such Purchaser\u2019s \u201cConvertible Security Shares\u201d), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and any original Convertible Securities held by (or delivered (electronically or otherwise) to) the Company may be cancelled (and marked cancelled) by the Company upon or following the Initial Closing; and\n\nAs to such Purchaser, such Purchaser\u2019s Convertible Security Shares are issued in full and complete discharge and satisfaction of all obligations of the Company (including outstanding principal, interest or any other amounts) under such Purchaser\u2019s Convertible Securities, and such Convertible Securities will be terminated and of no further force or effect automatically immediately upon the Initial Closing.\n\n[The Company and its Affiliates and agents shall be entitled to deduct and withhold from the amounts deliverable pursuant to Purchaser\u2019s Convertible Securities (including any Convertible Security Shares otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of the Transaction Agreements as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this", "position": 13419, "entities": [{"text": "the Outside Date", "label": "ORG", "start": 123, "end": 139}, {"text": "Common Stock", "label": "ORG", "start": 222, "end": 234}, {"text": "Deemed Liquidation Event", "label": "ORG", "start": 273, "end": 297}, {"text": "the Restated Certificate", "label": "ORG", "start": 313, "end": 337}, {"text": "at least 10", "label": "CARDINAL", "start": 416, "end": 427}, {"text": "Termination Event", "label": "ORG", "start": 471, "end": 488}, {"text": "Purchaser", "label": "ORG", "start": 504, "end": 513}, {"text": "Elective Closing", "label": "ORG", "start": 531, "end": 547}, {"text": "Termination Event", "label": "ORG", "start": 562, "end": 579}, {"text": "Purchaser", "label": "ORG", "start": 657, "end": 666}, {"text": "Shares", "label": "ORG", "start": 698, "end": 704}, {"text": "Purchaser", "label": "ORG", "start": 729, "end": 738}, {"text": "Closing", "label": "PERSON", "start": 747, "end": 754}, {"text": "Company", "label": "ORG", "start": 826, "end": 833}, {"text": "Company", "label": "ORG", "start": 888, "end": 895}, {"text": "Company", "label": "ORG", "start": 1277, "end": 1284}, {"text": "the \u201cConvertible Securities", "label": "ORG", "start": 1472, "end": 1499}, {"text": "all Convertible Securities", "label": "ORG", "start": 1564, "end": 1590}, {"text": "Purchaser", "label": "ORG", "start": 1604, "end": 1613}, {"text": "Exhibit", "label": "PERSON", "start": 1630, "end": 1637}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1844, "end": 1855}, {"text": "Exhibit", "label": "PERSON", "start": 1864, "end": 1871}, {"text": "Purchaser\u2019s Convertible Securities", "label": "ORG", "start": 1912, "end": 1946}], "key_terms": ["1.2", "8", "9", "10"], "title": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the consummation of the Company\u2019s first underwritten public offering of its Common Stock, under the Securities Act, or (iii) a Deemed Liquidation Event (as defined in the Restated Certificate) (each, a \u201cTermination Event\u201d). The Company shall provide each Purchaser with at least 10 business days\u2019 prior written notice of any Termination Event to enable each Purchaser to consummate an Elective Closing prior to such Termination Event.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Conversion Rights clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1986", "1.3", "1"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 9, "type": "General Clause", "text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "full_text": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge Parties\u201d means [(i)] the Officers [and (ii) solely for purposes of", "position": 21034, "entities": [{"text": "Company", "label": "ORG", "start": 89, "end": 96}], "key_terms": ["2"], "title": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["2.8", "1933", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 11, "type": "Board Control", "text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "full_text": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board of Directors, which determination shall include the approval by [a majority] of the Preferred Directors (as defined in the Restated Certificate) then serving, [and (y) the Requisite Purchasers] of the achievement of the Milestones; and (ii) the written waiver of the achievement of the Milestones by the Requisite Purchasers, which waiver may be given or withheld by such Purchasers in their sole discretion.\n\n\u201cTranche Closing Date\u201d means [a date that is no earlier than [10] business days and no later than [20] business days following delivery of the Tranche Closing Notice to the Purchasers].\n\n\u201cTransaction Agreements\u201d means this Agreement, the Investors\u2019 Rights Agreement, the Management Rights Letter[s], the Right of First Refusal and Co-Sale Agreement, the Voting Agreement and [list any other agreements, instruments or documents entered into in connection with this Agreement, such as the Indemnification Agreement and new side letters].\n\n\u201cVoting Agreement\u201d means the agreement among the Company, the Purchasers and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0H attached to this Agreement.\n\nRepresentations and Warranties of the Company\n\n. The Company hereby represents and warrants to each Purchaser that, except as set forth on the Disclosure Schedule attached as Exhibit\u00a0C to this Agreement, which exceptions shall be deemed to be part of the representations and warranties made hereunder, the following representations are true and complete as of the date of the [Initial][applicable] Closing, except as otherwise indicated. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections contained in this", "position": 22607, "entities": [{"text": "Tranche Closing Condition", "label": "ORG", "start": 51, "end": 76}, {"text": "the Board of Directors", "label": "ORG", "start": 140, "end": 162}, {"text": "the Preferred Directors", "label": "ORG", "start": 230, "end": 253}, {"text": "the Restated Certificate", "label": "ORG", "start": 269, "end": 293}, {"text": "the Requisite Purchasers", "label": "ORG", "start": 450, "end": 474}, {"text": "Purchasers", "label": "PERSON", "start": 522, "end": 532}, {"text": "Tranche Closing Date", "label": "ORG", "start": 561, "end": 581}, {"text": "20", "label": "CARDINAL", "start": 659, "end": 661}, {"text": "the Tranche Closing Notice", "label": "ORG", "start": 699, "end": 725}, {"text": "the Management Rights Letter[s", "label": "ORG", "start": 827, "end": 857}, {"text": "the Right of First Refusal", "label": "ORG", "start": 860, "end": 886}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 891, "end": 908}, {"text": "Company", "label": "ORG", "start": 1147, "end": 1154}, {"text": "Purchasers", "label": "ORG", "start": 1160, "end": 1170}, {"text": "Company", "label": "ORG", "start": 1209, "end": 1216}, {"text": "the Initial Closing", "label": "ORG", "start": 1242, "end": 1261}, {"text": "Exhibit\u00a0H", "label": "ORG", "start": 1278, "end": 1287}, {"text": "Purchaser", "label": "ORG", "start": 1417, "end": 1426}], "key_terms": ["20", "2.10", "10"], "title": "Section 2.10(a)(iii) of the Disclosure Schedule.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Investor majority board control", "Founders can be outvoted on critical decisions", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": ["majority"]}, {"id": 12, "type": "Representations & Warranties", "text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "full_text": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.\n\nFor purposes of these representations and warranties (other than those in Sections 2.2, 2.3, 2.4, 2.5, 2.6[, 2.21, 2.22, 2.23, 2.24] and 2.32 [and the second to last sentence of", "position": 24486, "entities": [{"text": "2.3", "label": "DATE", "start": 343, "end": 346}, {"text": "2.4", "label": "CARDINAL", "start": 348, "end": 351}, {"text": "2.5", "label": "CARDINAL", "start": 353, "end": 356}, {"text": "2.6", "label": "CARDINAL", "start": 358, "end": 361}, {"text": "2.21", "label": "CARDINAL", "start": 364, "end": 368}, {"text": "2.22", "label": "CARDINAL", "start": 370, "end": 374}, {"text": "2.23", "label": "CARDINAL", "start": 376, "end": 380}, {"text": "2.24", "label": "CARDINAL", "start": 382, "end": 386}], "key_terms": ["2.3", "2", "2.2", "2.4"], "title": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This Representations & Warranties clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 16, "type": "Vesting", "text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "position": 29523, "entities": [{"text": "Common Stock", "label": "ORG", "start": 62, "end": 74}, {"text": "monthly", "label": "DATE", "start": 196, "end": 203}, {"text": "four years", "label": "DATE", "start": 210, "end": 220}, {"text": "one-year", "label": "DATE", "start": 228, "end": 236}, {"text": "monthly", "label": "DATE", "start": 271, "end": 278}, {"text": "Company", "label": "ORG", "start": 386, "end": 393}, {"text": "the Company\u2019s Stock Plan", "label": "ORG", "start": 731, "end": 755}, {"text": "the Restated Certificate", "label": "ORG", "start": 1017, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1047, "end": 1054}, {"text": "Company", "label": "ORG", "start": 1153, "end": 1160}, {"text": "Shares", "label": "ORG", "start": 1242, "end": 1248}, {"text": "Company", "label": "ORG", "start": 1298, "end": 1305}, {"text": "Company", "label": "ORG", "start": 1547, "end": 1554}, {"text": "one", "label": "CARDINAL", "start": 1559, "end": 1562}, {"text": "the Board of Directors", "label": "ORG", "start": 1787, "end": 1809}, {"text": "Company", "label": "ORG", "start": 1867, "end": 1874}, {"text": "the Transaction Agreements", "label": "ORG", "start": 1889, "end": 1915}, {"text": "Shares", "label": "ORG", "start": 1934, "end": 1940}, {"text": "the Common Stock", "label": "ORG", "start": 1973, "end": 1989}], "key_terms": ["2.2"], "title": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock.", "risk_level": "Medium", "confidence": 0.7, "explanation": "Standard 4-year vesting with 1-year cliff. Common but limits founder flexibility.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 19, "type": "IP Assignment", "text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "full_text": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.\n\nThe Company is not a guarantor or indemnitor of any indebtedness of any other Person.\n\nCertain Transactions.\n\nOther than (i) standard employee benefits generally made available to all employees, standard employee offer letters and Confidential Information Agreements; (ii) standard director and officer indemnification agreements approved by the Board of Directors; (iii) the purchase of shares of the Company\u2019s capital stock and the issuance of options to purchase shares of the Company\u2019s Common Stock, in each instance, approved in the written minutes of the Board of Directors (previously made available to the Purchasers or their respective counsel); and (iv) the Transaction Agreements, there are no agreements, understandings or proposed transactions between the Company and any of its Officers or directors, or any Affiliate thereof. \n\nThe Company is not indebted, directly or indirectly, to any of its directors, officers or employees or to their respective spouses or children or to any Affiliate of any of the foregoing, other than in connection with expenses or advances of expenses incurred in the ordinary course of business or employee relocation expenses and for other customary employee benefits made generally available to all employees. None of the Company\u2019s directors, officers or employees [or consultants], or any members of their immediate families, or any Affiliate of the foregoing are, directly or indirectly, indebted to the Company or, to the Company\u2019s knowledge, have any (i) material commercial, industrial, banking, consulting, legal, accounting, charitable or familial relationship with the Company or any of the Company\u2019s customers, suppliers, service providers, joint venture partners, licensees and competitors, (ii) direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation which competes with the Company except that directors, officers, employees or stockholders of the Company may own stock in (but not exceeding 2% of the outstanding capital stock of) publicly traded companies that may compete with the Company; or (iii) financial interest in any [material] contract with the Company. \n\nRights of Registration and Voting Rights\n\n. Except as provided in the Investors\u2019 Rights Agreement, the Company is not under any obligation to register under the Securities Act any of its currently outstanding securities or any securities issuable upon exercise or conversion of its currently outstanding securities. To the Company\u2019s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company.\n\nTangible and Real Property\n\n. The tangible and real property and assets that the Company owns are free and clear of all mortgages, deeds of trust, liens, loans and encumbrances, except for statutory liens for the payment of current taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets. With respect to the tangible and real property and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free of any liens, claims or encumbrances other than those of the lessors of such property or assets. The Company does not own any real property. \n\n[Financial Statements\n\n;] Liabilities. [The Company has delivered to each Purchaser its [unaudited] [audited] financial statements (including balance sheet, income statement and statement of cash flows) as of and for the fiscal year ended [_______ __], 20[_] [and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) as of [_______ __], 20[_] (the \u201cBalance Sheet Date\u201d) and for the [_____]-month period ended on the Balance Sheet Date] (collectively, the \u201cFinancial Statements\u201d). The Financial Statements have been prepared in accordance with GAAP applied on a consistent basis throughout the periods indicated[, except that the unaudited Financial Statements may not contain all footnotes required by GAAP]. The Financial Statements fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit adjustments. Except as set forth in the Financial Statements, the] [The] Company has no material liabilities or obligations, contingent or otherwise, other than (i)\u00a0liabilities incurred in the ordinary course of business subsequent to [the Balance Sheet Date]; (ii)\u00a0obligations under contracts and commitments incurred in the ordinary course of business; and (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in [the Financial Statements] [financial statements], which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP. \n\nChanges\n\n. Since the [Balance Sheet Date], there has not been:\n\nany change in the assets, liabilities, financial condition or operating results of the Company[ from that reflected in the Financial Statements], except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;\n\nany damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;\n\nany waiver or compromise by the Company of a valuable right or of a material debt owed to it;\n\nany satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;\n\nany material change to a material contract or agreement by which the Company or any of its assets is bound or subject;\n\nany material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;\n\nany resignation or termination of employment of any Officer; \n\nany mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company\u2019s ownership or use of such property or assets;\n\nany loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;\n\nany declaration, setting aside or payment or other distribution in respect of any of the Company\u2019s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company;\n\nany sale, assignment or transfer by the Company of any Company-Controlled Intellectual Property that could reasonably be expected to result in a Material Adverse Effect;\n\nreceipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company;\n\nany other event or condition of any character, other than events affecting the economy or the Company\u2019s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or\n\nany arrangement or commitment by the Company to do any of the things described in this", "position": 48939, "entities": [{"text": "Persons the Company", "label": "ORG", "start": 159, "end": 178}, {"text": "Certain Transactions", "label": "PERSON", "start": 423, "end": 443}, {"text": "Confidential Information Agreements", "label": "ORG", "start": 567, "end": 602}, {"text": "the Board of Directors", "label": "ORG", "start": 678, "end": 700}, {"text": "Company", "label": "ORG", "start": 738, "end": 745}, {"text": "the Company\u2019s Common Stock", "label": "ORG", "start": 812, "end": 838}, {"text": "the Board of Directors", "label": "ORG", "start": 893, "end": 915}, {"text": "Purchasers", "label": "ORG", "start": 950, "end": 960}, {"text": "Company", "label": "ORG", "start": 1105, "end": 1112}, {"text": "Affiliate", "label": "ORG", "start": 1158, "end": 1167}, {"text": "Affiliate", "label": "ORG", "start": 1332, "end": 1341}, {"text": "Affiliate", "label": "ORG", "start": 1715, "end": 1724}, {"text": "Company", "label": "ORG", "start": 1787, "end": 1794}, {"text": "Company", "label": "ORG", "start": 1958, "end": 1965}, {"text": "2%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["20", "2.10", "2%"], "title": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (including Persons the Company has reason to believe are affiliated with each other) shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such section.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale, compensation. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 20, "type": "General Clause", "text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "full_text": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with such employee\u2019s ability to promote the interest of the Company or that would conflict with the Company\u2019s business. Neither the execution or delivery of the Transaction Agreements, nor the carrying on of the Company\u2019s business by the employees of the Company, nor the conduct of the Company\u2019s business as now conducted and as presently proposed to be conducted, will[, to the Company\u2019s knowledge,] conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee is now obligated. \n\nThe Company is not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries, commissions, bonuses, or other direct compensation for any service performed for it prior to the date hereof or amounts required to be reimbursed to such employees, consultants or independent contractors. The Company has complied in all material respects with all applicable state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours, worker classification and collective bargaining. The Company has withheld and paid to the appropriate governmental entity or is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Company and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.\n\nTo the Company\u2019s knowledge, no Officer intends to terminate employment with the Company or is otherwise likely to become unavailable to continue as an employee. The Company does not have a present intention to terminate the employment of any of the foregoing. The employment of each employee of the Company is terminable at the will of the Company. Except as set forth in", "position": 57010, "entities": [{"text": "2.15", "label": "CARDINAL", "start": 8, "end": 12}, {"text": "Company", "label": "ORG", "start": 416, "end": 423}, {"text": "Company", "label": "ORG", "start": 571, "end": 578}, {"text": "Company", "label": "ORG", "start": 1705, "end": 1712}, {"text": "Company", "label": "ORG", "start": 1918, "end": 1925}], "key_terms": ["2.15"], "title": "Section\u00a02.15.", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 24, "type": "General Clause", "text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "full_text": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]\n\n[Qualified Small Business Stock\n\n. As of and immediately following the [Initial] Closing: (i) the Company will be an eligible corporation as defined in", "position": 66488, "entities": [{"text": "Hazardous Substance", "label": "ORG", "start": 144, "end": 163}, {"text": "Hazardous Substances", "label": "ORG", "start": 342, "end": 362}, {"text": "Qualified Small Business Stock\n\n", "label": "ORG", "start": 367, "end": 399}], "key_terms": ["2.22"], "title": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection of employee health or safety, public health or the environment; or (c)\u00a0the manufacture, handling, transport, use, treatment, storage, or disposal of Hazardous Substances.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 25, "type": "General Clause", "text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "full_text": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.] \n\n[Small Business Concern\n\n. The Company together with its \u201caffiliates\u201d (as that term is defined in", "position": 67006, "entities": [{"text": "Company", "label": "ORG", "start": 41, "end": 48}, {"text": "one-year", "label": "DATE", "start": 146, "end": 154}, {"text": "Company", "label": "ORG", "start": 313, "end": 320}, {"text": "$75 million", "label": "MONEY", "start": 471, "end": 482}, {"text": "Purchasers", "label": "ORG", "start": 693, "end": 703}, {"text": "Company", "label": "ORG", "start": 803, "end": 810}, {"text": "Company", "label": "ORG", "start": 956, "end": 963}, {"text": "$75 million", "label": "MONEY", "start": 0, "end": 0}], "key_terms": ["4", "3", "1202", "1.1202"], "title": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-year period preceding the [Initial] Closing, except for purchases that are disregarded for such purposes under Treasury Regulation Section 1.1202-2, and (iii) the Company\u2019s aggregate gross assets, as defined by Code Section 1202(d)(2), at no time between its incorporation and through the [Initial] Closing have exceeded $75 million, taking into account the assets of any corporations required to be aggregated with the Company in accordance with Code Section 1202(d)(3); provided, however, that in no event shall the Company be liable to the Purchasers or any other party for any damages arising from any subsequently proven or identified error in the Company\u2019s determination with respect to the applicability or interpretation of Code Section 1202, unless such determination shall have been given by the Company in a manner either grossly negligent or fraudulent.]", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 26, "type": "Representations & Warranties", "text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "position": 68123, "entities": [{"text": "CFR", "label": "ORG", "start": 65, "end": 68}, {"text": "concern\u201d][\u201csmaller", "label": "PERSON", "start": 94, "end": 112}, {"text": "the Small Business Investment Act", "label": "ORG", "start": 146, "end": 179}, {"text": "1958", "label": "DATE", "start": 183, "end": 187}, {"text": "the \u201cSmall Business Act", "label": "ORG", "start": 201, "end": 224}, {"text": "107.710", "label": "CARDINAL", "start": 331, "end": 338}, {"text": "Purchaser", "label": "ORG", "start": 398, "end": 407}, {"text": "Small Business Investment Company", "label": "ORG", "start": 427, "end": 460}, {"text": "SBA Forms", "label": "ORG", "start": 486, "end": 495}, {"text": "480", "label": "CARDINAL", "start": 496, "end": 499}, {"text": "652", "label": "CARDINAL", "start": 501, "end": 504}, {"text": "1031", "label": "DATE", "start": 509, "end": 513}, {"text": "Company", "label": "ORG", "start": 573, "end": 580}, {"text": "CFR", "label": "ORG", "start": 670, "end": 673}, {"text": "SBIC Purchaser", "label": "PERSON", "start": 710, "end": 724}, {"text": "Company", "label": "ORG", "start": 853, "end": 860}, {"text": "the U.S. Foreign Corrupt Practices Act", "label": "ORG", "start": 1174, "end": 1212}, {"text": "Company", "label": "ORG", "start": 1758, "end": 1765}], "key_terms": ["13", "1958", "121.103", "121.301"], "title": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["721", "31", "1950", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 28, "type": "Board Control", "text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "full_text": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]\n\nSanctions\n\n. (a) [Since April 24, 2019], the Company and its subsidiaries have complied [in all material respects] with applicable laws and regulations pertaining to trade and economic sanctions administered by the United States[, European Union, or United Kingdom] (collectively, \u201cSanctions\u201d). (b) None of the Company, its subsidiaries, or their respective directors, officers, employees, or, to the Company\u2019s knowledge, the Company\u2019s or subsidiaries\u2019 agents is: (i) organized under the laws of, ordinarily resident in, or located in a country or territory that is the subject of comprehensive Sanctions (\u201cRestricted Countries\u201d); (ii) 50% or more owned or controlled by the government of a Restricted Country; or (iii) (A) designated on a sanctioned parties list administered by the United States[, European Union, or United Kingdom], including, without limitation, the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019s Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, [and ]Sectoral Sanctions Identification List[, the Consolidated List of Persons, Groups, and Entities Subject to EU Financial Sanctions, and the UK\u2019s Consolidated Sanctions List] (collectively, \u201cDesignated Parties\u201d); or (B) 50% or more owned or, where relevant under applicable Sanctions, controlled, individually or in the aggregate, by one or more Designated Party, in each case only to the extent that dealings with such persons are prohibited pursuant to applicable Sanctions (collectively, \u201cSanctioned Parties\u201d). (c) [Since April 24, 2019], none of the Company, its subsidiaries, or any of their respective officers, directors, or employees: (i) has been the subject or target of any investigation, prosecution, other enforcement action, or government inquiry related to Sanctions violations; or (ii) submitted a voluntary self-disclosure to any U.S. [or, [to the Company\u2019s knowledge,] other relevant] government agency regarding actual or potential Sanctions violations.\u00a0(d) The Company maintains policies and procedures reasonably designed to promote compliance with applicable Sanctions.\n\n[FCC Regulation and Compliance\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the Federal Communications Commission (\u201cFCC\u201d) or any other state or foreign agencies or bodies engaged in the regulation of [telecommunications, media, equipment manufacturers, and technology companies]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in disqualification under the FCC\u2019s rules or any similar law, rule or regulation of any other governmental entities. (c) To the Company\u2019s knowledge, neither the Company nor any of its officers or employees is the subject of any pending or threatened investigation by FCC or by any other similar governmental entity. (d) Neither the Company nor any of its officers or employees has made any materially false statements on, or material omissions from, any notifications, applications, reports and other submissions to the FCC or any similar governmental entity. (e) The Company is and has been in material compliance with the Communications Act of 1934, as amended, and all applicable rules and regulations of the FCC or any similar governmental entity.]\n\nNot a Covered Outbound Investment\n\n. (a) The Company either is (i) not a \u201cperson of a country of concern\u201d; or (ii) not engaged in any \u201ccovered activity,\u201d as these terms are defined in 31 C.F.R. Part 850, as implemented or revised from time to time (the \u201cOutbound Investment Security Program\u201d). (b) The Company has no intention of becoming a \u201cperson of a country of concern\u201d that engages in any \u201ccovered activity.\u201d [(c) The Company is not, and does not intend to become, a person that directly or indirectly holds a board seat or a voting or equity interest in, or any contractual power to direct or cause the direction of the management of policies of, any \u201ccovered foreign person\u201d as defined in the Outbound Investment Security Program.]\n\nData Security Program\n\n. The Company is not a \u201ccovered person\u201d as defined in Executive Order 14117 and rules and regulations issued thereunder, including 28 C.F.R. Part 202, as implemented or amended from time to time (the \u201cDSP\u201d).  Since April 8, 2025, the Company has not knowingly engaged in or directed any \u201ccovered data transaction\u201d as that term is defined in the DSP, except in compliance with the DSP.  [The Company maintains policies and procedures reasonably designed to promote compliance with the DSP.]\n\nDisclosure\n\n. The Company has made available to the Purchasers all the information that the Purchasers have requested for deciding whether to acquire the Shares, including certain of the Company\u2019s projections describing its proposed business plan (the \u201cBusiness Plan\u201d). No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or, to the Company\u2019s knowledge, omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made. The Business Plan was prepared in good faith; however, the Company does not warrant that it will achieve any results projected in the Business Plan. It is understood that this representation is qualified by the fact that the Company has not delivered to the Purchasers, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure of the types of information customarily furnished to purchasers of securities.\n\nRepresentations and Warranties of the Purchasers\n\n. Each Purchaser hereby represents and warrants to the Company, severally and not jointly, that:\n\nAuthorization\n\n. The Purchaser has full power and authority to enter into the Transaction Agreements. The Transaction Agreements to which the Purchaser is a party, when executed and delivered by the Purchaser, will constitute valid and legally binding obligations of the Purchaser, enforceable against such Purchaser in accordance with their terms, except (a)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application affecting enforcement of creditors\u2019 rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (b)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement may be limited by applicable federal or state securities laws. \n\nPurchase Entirely for Own Account\n\n. This Agreement is made with the Purchaser in reliance upon the Purchaser\u2019s representation to the Company, which by the Purchaser\u2019s execution of this Agreement, the Purchaser hereby confirms, that the Shares to be acquired by the Purchaser will be acquired for investment for the Purchaser\u2019s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. \n\nDisclosure of Information\n\n. The Purchaser has had an opportunity to discuss the Company\u2019s business, management, financial affairs and the terms and conditions of the offering of the Shares with the Company\u2019s management and has had an opportunity to review the Company\u2019s facilities. The foregoing, however, does not limit or modify the representations and warranties of the Company in", "position": 79902, "entities": [{"text": "FDA", "label": "ORG", "start": 271, "end": 274}, {"text": "56", "label": "CARDINAL", "start": 389, "end": 391}, {"text": "Fed", "label": "ORG", "start": 392, "end": 395}, {"text": "Reg", "label": "PERSON", "start": 397, "end": 400}, {"text": "46191", "label": "DATE", "start": 402, "end": 407}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 409, "end": 425}, {"text": "the \u201c", "label": "ORG", "start": 428, "end": 433}, {"text": "FDA Application Integrity Policy", "label": "ORG", "start": 433, "end": 465}, {"text": "FDA", "label": "ORG", "start": 846, "end": 849}, {"text": "FDA", "label": "ORG", "start": 942, "end": 945}, {"text": "the FDA Application Integrity Policy", "label": "ORG", "start": 956, "end": 992}, {"text": "April 24, 2019", "label": "DATE", "start": 1086, "end": 1100}, {"text": "Company", "label": "ORG", "start": 1107, "end": 1114}, {"text": "European Union", "label": "ORG", "start": 1293, "end": 1307}, {"text": "50%", "label": "PERCENT", "start": 1698, "end": 1701}, {"text": "European Union", "label": "ORG", "start": 1862, "end": 1876}, {"text": "the U.S. Department of the Treasury\u2019s Office of Foreign Assets Control\u2019", "label": "ORG", "start": 1929, "end": 2000}, {"text": "October\u00a010, 1991", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "April 24, 2019", "label": "DATE", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}, {"text": "50%", "label": "PERCENT", "start": 0, "end": 0}], "key_terms": ["56", "1320", "46191", "10", "7"], "title": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, to the Company\u2019s knowledge, any of its contractors or agents is the subject of any pending or threatened investigation by FDA pursuant to its \u201cFraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities\u201d policy as stated at 56 Fed. Reg. 46191 (October\u00a010, 1991) (the \u201cFDA Application Integrity Policy\u201d) and any amendments thereto, or by any other similar governmental entity pursuant to any similar policy. (d) Neither the Company nor any of its officers, employees, or to the Company\u2019s knowledge, any of its contractors or agents has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions to FDA or any similar governmental entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar governmental entity to invoke a similar policy.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["501", "1933", "11"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 31, "type": "Board Control", "text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "full_text": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction. \n\n[CFIUS Foreign Person Status\n\n. [Except for Purchasers indicated as Known Foreign Purchasers on Exhibit A,] The Purchaser is not a \u201cforeign person\u201d or a \u201cforeign entity\u201d and is not controlled by a \u201cforeign person,\u201d as those terms are defined in the DPA. The Purchaser does not permit any foreign person affiliated with the Purchaser, whether affiliated as a limited partner or equivalent, to obtain through the Purchaser as a result of that foreign person\u2019s investment any of the following with respect to the Company: (i) access to any \u201cmaterial nonpublic technical information\u201d (as defined in the DPA) in the possession of the Company; (ii) membership or observer rights on the Board of Directors or equivalent governing body of the Company or the right to nominate an individual to a position on the Board of Directors or equivalent governing body of the Company; (iii) any \u201cinvolvement,\u201d other than through the voting of shares, in the \u201csubstantive decisionmaking\u201d of the Company (as defined in the DPA) regarding (x) the use, development, acquisition, or release of any \u201ccritical technology\u201d (as defined in the DPA), (y) the use, development, acquisition, safekeeping, or release of \u201csensitive personal data\u201d (as defined in the DPA) of U.S. citizens maintained or collected by the Company, or (z) the management, operation, manufacture, or supply of \u201ccovered investment critical infrastructure\u201d (as defined in the DPA); or (iv) \u201ccontrol\u201d of the Company (as defined in the DPA).]\n\nSanctions\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners, is a Sanctioned Party.\n\nNo General Solicitation\n\n. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (a)\u00a0engaged in any general solicitation, or (b)\u00a0published any advertisement in connection with the offer and sale of the Shares.\n\nExculpation Among Purchasers\n\n. The Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors, in making its investment or decision to invest in the Company. The Purchaser agrees that neither any Purchaser nor the respective controlling Persons, officers, directors, partners, agents, or employees of any Purchaser shall be liable to any other Purchaser for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Shares.\n\nResidence\n\n. If the Purchaser is an individual, then the Purchaser resides in the state or province identified in the address of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A; if the Purchaser is a partnership, corporation, limited liability company or other entity, then the office or offices of the Purchaser in which it has its principal place of business is identified in the address or addresses of the Purchaser set forth on the Purchaser\u2019s signature page or Exhibit\u00a0A.\n\n[Not a Person of a Country of Concern\n\n. Except as otherwise disclosed in writing to the Company, the Purchaser is not a \u201cperson of a country of concern\u201d within the meaning of the Outbound Investment Security Program.]\n\n[Data Security Program\n\n. The Purchaser is not a \u201ccovered person\u201d as that term is defined in the DSP.]\n\nConditions to the Purchasers\u2019 Obligations at Closing\n\n. The obligations of each Purchaser to purchase Shares at the [Initial] Closing [or any subsequent Closing] are subject to the fulfillment, on or before the [Initial/applicable] Closing, of each of the following conditions, unless otherwise waived by Purchasers purchasing [at least [___]%/a majority] of the Shares in such Closing, in their sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of the Company contained in", "position": 92595, "entities": [{"text": "Shares", "label": "PERSON", "start": 208, "end": 214}, {"text": "Shares", "label": "ORG", "start": 330, "end": 336}, {"text": "Shares", "label": "ORG", "start": 621, "end": 627}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 633, "end": 644}, {"text": "Shares", "label": "ORG", "start": 716, "end": 722}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 787, "end": 798}, {"text": "Known Foreign Purchasers on Exhibit A", "label": "ORG", "start": 883, "end": 920}, {"text": "Purchaser", "label": "ORG", "start": 927, "end": 936}, {"text": "DPA", "label": "ORG", "start": 1064, "end": 1067}, {"text": "Purchaser", "label": "ORG", "start": 1073, "end": 1082}, {"text": "Purchaser", "label": "ORG", "start": 1138, "end": 1147}, {"text": "Purchaser", "label": "ORG", "start": 1226, "end": 1235}, {"text": "DPA", "label": "ORG", "start": 1414, "end": 1417}, {"text": "Company", "label": "ORG", "start": 1444, "end": 1451}, {"text": "the Board of Directors", "label": "ORG", "start": 1491, "end": 1513}, {"text": "Company", "label": "ORG", "start": 1550, "end": 1557}, {"text": "the Board of Directors", "label": "ORG", "start": 1614, "end": 1636}, {"text": "Company", "label": "ORG", "start": 1673, "end": 1680}, {"text": "DPA", "label": "ORG", "start": 1818, "end": 1821}, {"text": "DPA", "label": "ORG", "start": 1931, "end": 1934}], "key_terms": ["7701", "30"], "title": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Agreement, including (i)\u00a0the legal requirements within its jurisdiction for the purchase of the Shares, (ii)\u00a0any foreign exchange restrictions applicable to such purchase, (iii)\u00a0any governmental or other consents that may need to be obtained, and (iv)\u00a0the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. The Purchaser\u2019s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of the Purchaser\u2019s jurisdiction.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 32, "type": "Board Control", "text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "full_text": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].\n\nPerformance\n\n. The Company shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company in all respects on or before the [Initial] Closing [and, as to any subsequent Closing, in all material respects on or before such subsequent Closing].\n\nCompliance Certificate\n\n. The Chief Executive Officer or President of the Company shall deliver to the Purchasers at the [Initial/applicable] Closing a certificate certifying that the conditions specified in Sections\u00a04.1 and 4.2 have been fulfilled.\n\nQualifications\n\n. Except for any notices required or permitted to be filed with certain federal and state securities commissions after the [applicable/Initial] Closing, all authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the applicable Closing.\n\n[Opinion of Company Counsel\n\n. The Purchasers shall have received from [___________], counsel for the Company, an opinion, dated as of the [Initial] Closing, in substantially the form of Exhibit\u00a0I attached to this Agreement.]\n\n[Board of Directors\n\n. As of the [Initial] Closing, the authorized size of the Board of Directors shall be [______], and the Board of Directors shall be comprised of [_________________].]\n\nIndemnification Agreement\n\n. The Company shall have executed and delivered the Indemnification Agreements.\n\nInvestors\u2019 Rights Agreement\n\n. The Company and each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder) [and the other stockholders of the Company named as parties thereto] shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. The Company, each Purchaser (other than the Purchaser relying upon this condition to excuse such Purchaser\u2019s performance hereunder), and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\nRestated Certificate\n\n. The Company shall have filed the Restated Certificate with the Secretary of State of Delaware on or prior to the [Initial] Closing, which shall continue to be in full force and effect as of the [Initial] Closing.\n\nSecretary\u2019s Certificate\n\n. The Secretary of the Company shall have delivered to the Purchasers at the [Initial] Closing a certificate certifying (i) the Certificate of Incorporation and Bylaws of the Company as in effect at the [Initial] Closing; (ii) resolutions of the Board of Directors approving the Restated Certificate, the Transaction Agreements and the transactions contemplated under the Transaction Agreements; and (iii) resolutions of the stockholders of the Company approving the Restated Certificate.\n\nProceedings and Documents\n\n. All corporate and other proceedings in connection with the transactions contemplated at the [Initial] Closing and all documents incidental thereto shall be reasonably satisfactory in form and substance to each Purchaser, and each Purchaser (or its respective counsel) shall have received all such counterpart original and certified or other copies of such documents as reasonably requested. Such documents may include good standing certificates.  \n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_________] Shares must be sold at the [Initial] Closing.] \n\n[Management Rights\n\n. A Management Rights Letter shall have been executed by the Company and delivered to each Purchaser to whom it is addressed.]\n\n[SBA Matters\n\n. The Company shall have executed and delivered to each SBIC Purchaser a Size Status Declaration on SBA Form 480 and an Assurance of Compliance on SBA Form 652, and shall have provided to each such Purchaser information necessary for the preparation of a Portfolio Financing Report on SBA Form 1031.]\n\nConditions of the Company\u2019s Obligations at Closing\n\n. The obligations of the Company to sell Shares to the Purchasers at the [Initial] Closing or any subsequent Closing are subject to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived by the Company in its sole discretion:\n\nRepresentations and Warranties\n\n. The representations and warranties of each Purchaser purchasing Shares in such Closing contained in", "position": 97237, "entities": [{"text": "the Disclosure Schedule", "label": "ORG", "start": 26, "end": 49}, {"text": "Closing", "label": "PERSON", "start": 148, "end": 155}, {"text": "Closing", "label": "PERSON", "start": 507, "end": 514}, {"text": "Purchasers", "label": "ORG", "start": 684, "end": 694}, {"text": "4.1", "label": "CARDINAL", "start": 798, "end": 801}, {"text": "4.2", "label": "CARDINAL", "start": 806, "end": 809}, {"text": "Shares", "label": "ORG", "start": 1210, "end": 1216}, {"text": "Opinion of Company Counsel", "label": "ORG", "start": 1308, "end": 1334}, {"text": "Purchasers", "label": "ORG", "start": 1342, "end": 1352}, {"text": "Company", "label": "ORG", "start": 1409, "end": 1416}, {"text": "Exhibit", "label": "PERSON", "start": 1494, "end": 1501}, {"text": "Board of Directors", "label": "ORG", "start": 1535, "end": 1553}, {"text": "the Board of Directors", "label": "ORG", "start": 1609, "end": 1631}, {"text": "the Board of Directors", "label": "ORG", "start": 1655, "end": 1677}, {"text": "Purchaser", "label": "ORG", "start": 1883, "end": 1892}, {"text": "Purchaser", "label": "ORG", "start": 1962, "end": 1971}], "key_terms": ["652", "480", "4.1", "4.2", "2"], "title": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Closing, in all material respects as of such subsequent Closing].", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 33, "type": "Representations & Warranties", "text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "full_text": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by them on or before the applicable Closing.\n\nQualifications\n\n. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state that are required in connection with the lawful issuance and sale of the Shares pursuant to this Agreement shall be obtained and effective as of the Closing.\n\nInvestors\u2019 Rights Agreement\n\n. Each Purchaser shall have executed and delivered the Investors\u2019 Rights Agreement.\n\nRight of First Refusal and Co-Sale Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Right of First Refusal and Co-Sale Agreement.\n\nVoting Agreement\n\n. Each Purchaser and the other stockholders of the Company named as parties thereto shall have executed and delivered the Voting Agreement.\n\n[Minimum Number of Shares at [Initial] Closing\n\n. A minimum of [_______] Shares must be sold at the [Initial] Closing.]\n\nMiscellaneous\n\n.\n\nSurvival of Warranties\n\n. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the Purchasers or the Company.\n\nSuccessors and Assigns\n\n. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything herein to the contrary, no Shares may be transferred prior to the consummation or termination of the obligation to consummate the Tranche Closing unless all rights and obligations hereunder (including without limitation the obligations to consummate the Tranche Closing) are assigned to and assumed by the transferee.\n\nGoverning Law\n\n. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.\n\nCounterparts\n\n. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. \n\nTitles and Subtitles\n\n. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.\n\nNotices\n\n.\n\nGeneral. All notices and other communications given or made pursuant to this Agreement shall be in writing (including electronic mail as permitted in this Agreement) and shall be deemed effectively given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient\u2019s next business day; (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature page or Exhibit\u00a0A, or to such e-mail address or address as subsequently modified by written notice given in accordance with this", "position": 102262, "entities": [{"text": "Shares", "label": "ORG", "start": 592, "end": 598}, {"text": "Co-Sale Agreement\n\n", "label": "ORG", "start": 819, "end": 838}, {"text": "Purchaser", "label": "ORG", "start": 845, "end": 854}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 987, "end": 1004}, {"text": "Purchaser", "label": "ORG", "start": 1032, "end": 1041}, {"text": "Company", "label": "ORG", "start": 1419, "end": 1426}, {"text": "Purchasers", "label": "ORG", "start": 1435, "end": 1445}, {"text": "Purchasers", "label": "ORG", "start": 1693, "end": 1703}, {"text": "Assigns", "label": "PERSON", "start": 1736, "end": 1743}], "key_terms": ["3", "2000"], "title": "Section 3 shall be true and correct in all respects as of the applicable Closing.", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "25102", "1", "30", "25100"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 38, "type": "Representations & Warranties", "text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "full_text": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]\n\nFORM OF INDEMNIFICATION AGREEMENT\n\nFORM OF INVESTORS\u2019 RIGHTS AGREEMENT\n\nFORM OF MANAGEMENT RIGHTS LETTER\n\nForm of Right of First Refusal and Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares\n\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Purchaser\tInvested in Convertible Securities ($)\tConvertible Security Shares\tTotal Cash \nPurchase Price ($)\tShares Purchased by Cash\tTotal Shares at [Initial] Closing\tTranche Closing Shares\n\t\t\t\t\t\t\n[/TABLE]\n\n\n[TABLE]\nName and Address of Convertible Security Holder\tInvested in Convertible Securities ($)\tConvertible Security Shares\n\t\t\n[/TABLE]", "position": 122831, "entities": [{"text": "Purchasers", "label": "ORG", "start": 156, "end": 166}, {"text": "Exhibit", "label": "PERSON", "start": 177, "end": 184}, {"text": "Agreement", "label": "ORG", "start": 297, "end": 306}, {"text": "Agreement", "label": "ORG", "start": 440, "end": 449}, {"text": "1", "label": "CARDINAL", "start": 962, "end": 963}, {"text": "2", "label": "CARDINAL", "start": 1068, "end": 1069}, {"text": "3", "label": "CARDINAL", "start": 1172, "end": 1173}, {"text": "Agreement", "label": "ORG", "start": 1252, "end": 1261}, {"text": "4", "label": "CARDINAL", "start": 1305, "end": 1306}, {"text": "Purchasers", "label": "ORG", "start": 1717, "end": 1727}, {"text": "Co-Sale Agreement\n\nFORM OF VOTING AGREEMENT\n\nFORM OF LEGAL OPINION", "label": "ORG", "start": 1900, "end": 1966}, {"text": "Address of Pur", "label": "ORG", "start": 1986, "end": 2000}, {"text": "Company name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2", "3", "4", "1"], "title": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) and the Purchasers listed on Exhibit\u00a0A attached thereto. All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided, however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is readily apparent from the face of such disclosure. Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the ordinary course of business, (3) does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments. Such descriptions do not purport to be comprehensive and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been made available to the Purchasers or their respective counsel.]", "risk_level": "Medium", "confidence": 0.75, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}], "risk_assessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["2.8", "1933", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["721", "31", "1950", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1986", "1.3", "1"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "25102", "1", "30", "25100"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["501", "1933", "11"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "riskAssessment": {"overall_score": 32.4, "overall_level": "High", "risk_distribution": {"High": 18, "Medium": 19, "Low": 1}, "clause_count": 38, "dangerous_clauses": [{"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Board Control", "risk_level": "High", "risk_score": 0, "concern": "Founders lose control of the company. Investors can make unilateral decisions."}, {"type": "Representations & Warranties", "risk_level": "High", "risk_score": 0, "concern": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Conversion Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Liquidation Preference", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions."}, {"type": "IP Assignment", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"Board Control": {"count": 11, "risk_levels": {"High": 6, "Medium": 5, "Low": 0}}, "General Clause": {"count": 6, "risk_levels": {"High": 0, "Medium": 6, "Low": 0}}, "Pro-Rata Rights": {"count": 1, "risk_levels": {"High": 0, "Medium": 0, "Low": 1}}, "Conversion Rights": {"count": 5, "risk_levels": {"High": 2, "Medium": 3, "Low": 0}}, "IP Assignment": {"count": 5, "risk_levels": {"High": 4, "Medium": 1, "Low": 0}}, "Representations & Warranties": {"count": 4, "risk_levels": {"High": 1, "Medium": 3, "Low": 0}}, "Vesting": {"count": 1, "risk_levels": {"High": 0, "Medium": 1, "Low": 0}}, "Voting Rights": {"count": 4, "risk_levels": {"High": 4, "Medium": 0, "Low": 0}}, "Liquidation Preference": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 18, "risk_categories": {"operational": {"count": 16, "severity": "High", "clauses": [{"id": 10, "type": "Board Control", "text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "position": 21252, "entities": [{"text": "Company", "label": "ORG", "start": 85, "end": 92}, {"text": "Milestones", "label": "ORG", "start": 447, "end": 457}, {"text": "the Board of Directors", "label": "ORG", "start": 647, "end": 669}, {"text": "Purchasers", "label": "ORG", "start": 853, "end": 863}, {"text": "Shares", "label": "ORG", "start": 892, "end": 898}, {"text": "Co-Sale Agreement", "label": "ORG", "start": 964, "end": 981}, {"text": "Company", "label": "ORG", "start": 1013, "end": 1020}, {"text": "Purchasers", "label": "ORG", "start": 1026, "end": 1036}, {"text": "Company", "label": "ORG", "start": 1076, "end": 1083}, {"text": "the Initial Closing", "label": "ORG", "start": 1109, "end": 1128}, {"text": "Exhibit", "label": "PERSON", "start": 1145, "end": 1152}, {"text": "1933", "label": "DATE", "start": 1229, "end": 1233}], "key_terms": ["2.8", "1933", "1"], "title": "Section 2.8, [specify]].", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 13, "type": "Board Control", "text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "full_text": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Corporate Power and Qualification\n\n. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.\n\nCapitalization.\n\nThe authorized capital of the Company consists, immediately prior to the [Initial] Closing, of:\n\n[__________] shares of common stock, $[____] par value per share (the \u201cCommon Stock\u201d), [_________] shares of which are issued and outstanding. \n\n[__________] shares of preferred stock, $[____] par value per share (the \u201cPreferred Stock\u201d), of which [__________] shares have been designated Series\u00a0[___] Preferred Stock, none of which are issued and outstanding. The rights, privileges and preferences of the Preferred Stock are as stated in the Restated Certificate and as provided by the Delaware General Corporation Law (the \u201cDGCL\u201d). [The Company has issued Convertible Securities that will convert into an aggregate of [___] shares of Series [___] Preferred Stock as of the [Initial] Closing as set forth under the column heading \u201cConvertible Security Shares\u201d on Exhibit\u00a0A and Exhibit A-1.] Each share of Preferred Stock outstanding as of immediately prior to the [Initial] Closing will be convertible into one share of Common Stock as of immediately after the [Initial] Closing.\n\nAll of the outstanding shares of capital stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. \n\nThe Company has reserved [__________] shares of Common Stock for issuance to officers, directors, employees and consultants of the Company pursuant to its [insert Plan Year and Name] Plan duly adopted by the Board of Directors and approved by the Company stockholders (the \u201cStock Plan\u201d). Of such reserved shares of Common Stock, (i) [__________] shares have been issued pursuant to restricted stock purchase agreements and/or the exercise of options and are currently outstanding (and included as outstanding in", "position": 24919, "entities": [{"text": "Company", "label": "ORG", "start": 77, "end": 84}, {"text": "Good Standing", "label": "PERSON", "start": 132, "end": 145}, {"text": "Corporate Power", "label": "ORG", "start": 147, "end": 162}, {"text": "Qualification", "label": "ORG", "start": 167, "end": 180}, {"text": "Company", "label": "ORG", "start": 188, "end": 195}, {"text": "the State of Delaware", "label": "ORG", "start": 285, "end": 306}, {"text": "Company", "label": "ORG", "start": 661, "end": 668}, {"text": "[", "label": "MONEY", "start": 766, "end": 767}, {"text": "the \u201cCommon Stock", "label": "ORG", "start": 794, "end": 811}, {"text": "[", "label": "MONEY", "start": 914, "end": 915}, {"text": "the \u201cPreferred Stock", "label": "ORG", "start": 942, "end": 962}, {"text": "the Preferred Stock", "label": "ORG", "start": 1130, "end": 1149}, {"text": "the Restated Certificate", "label": "ORG", "start": 1167, "end": 1191}, {"text": "the Delaware General Corporation Law", "label": "ORG", "start": 1211, "end": 1247}, {"text": "Convertible Securities", "label": "ORG", "start": 1286, "end": 1308}, {"text": "Exhibit", "label": "PERSON", "start": 1492, "end": 1499}, {"text": "Preferred Stock", "label": "ORG", "start": 1534, "end": 1549}, {"text": "Common Stock", "label": "ORG", "start": 1649, "end": 1661}, {"text": "Common Stock", "label": "ORG", "start": 1952, "end": 1964}, {"text": "insert Plan Year and Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["2.25", "1"], "title": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.", "risk_level": "High", "confidence": 0.85, "explanation": "The clause allows investors to unilaterally appoint board members. This gives them significant control over company governance and decision-making without requiring founder approval.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments"], "specific_terms": []}, {"id": 14, "type": "Board Control", "text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "full_text": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder. \n\n[", "position": 27335, "entities": [{"text": "Common Stock", "label": "ORG", "start": 153, "end": 165}, {"text": "Company", "label": "ORG", "start": 327, "end": 334}, {"text": "Purchasers", "label": "ORG", "start": 356, "end": 366}], "key_terms": ["2.2"], "title": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan, all of which remain uncommitted and unallocated. The Company has furnished to the Purchasers complete and accurate copies of the Stock Plan and forms of agreements used thereunder.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 17, "type": "Voting Rights", "text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "position": 33243, "entities": [{"text": "Shares", "label": "ORG", "start": 91, "end": 97}, {"text": "The Common Stock", "label": "ORG", "start": 182, "end": 198}, {"text": "Shares", "label": "ORG", "start": 231, "end": 237}, {"text": "the Restated Certificate", "label": "ORG", "start": 325, "end": 349}, {"text": "Shares", "label": "ORG", "start": 792, "end": 798}, {"text": "Governmental Consents", "label": "ORG", "start": 885, "end": 906}, {"text": "Filings", "label": "ORG", "start": 911, "end": 918}, {"text": "Purchasers", "label": "ORG", "start": 979, "end": 989}], "key_terms": ["2.6", "3"], "title": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 21, "type": "Board Control", "text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "full_text": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.\n\nThe Company has not made any representations regarding equity incentives to any officer, employee, director or consultant that are inconsistent with the share amounts and terms set forth in the minutes of meetings of (or actions taken by unanimous written consent by) the Board of Directors. \n\nEach former officer or other employee who reported to the Chief Executive Officer, Chief Financial Officer, or Board of Directors has entered into an agreement with the Company providing for the full release of any claims against the Company or any related party arising out of such employment.", "position": 59220, "entities": [{"text": "Company", "label": "ORG", "start": 250, "end": 257}, {"text": "the Board of Directors", "label": "ORG", "start": 689, "end": 711}, {"text": "Board of Directors", "label": "ORG", "start": 826, "end": 844}, {"text": "Company", "label": "ORG", "start": 884, "end": 891}, {"text": "Company", "label": "ORG", "start": 949, "end": 956}], "key_terms": ["2.16"], "title": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other payments will become due. Except as set forth in Section\u00a02.16(c)(ii) of the Disclosure Schedule, the Company has no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 22, "type": "Board Control", "text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "full_text": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.\n\n[The Company is not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral, express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of the Company, has sought to represent any of the employees, representatives or agents of the Company. There is no strike or other labor dispute involving the Company pending, or to the Company\u2019s knowledge, threatened, which could have a Material Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.]\n\n[To the Company\u2019s knowledge, none of the Officers or directors of the Company has been (i)\u00a0subject to voluntary or involuntary petition under the federal bankruptcy laws or any state insolvency law or the appointment of a receiver, fiscal agent or similar officer by a court for such person\u2019s business or property; (ii)\u00a0convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii)\u00a0subject to any order, judgment or decree (not subsequently reversed, suspended, or vacated) of any court of competent jurisdiction permanently or temporarily enjoining such person from engaging, or otherwise imposing limits or conditions on such person\u2019s engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an officer or director of a public company; or (iv)\u00a0found by a court of competent jurisdiction in a civil action or by the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.]\n\n Tax Returns and Payments\n\n. There are no [income or other material] taxes due and payable by the Company\u00a0that have not been timely paid and no material withholding taxes required to be withheld by the Company that have not been withheld and timely paid over to the appropriate governmental agency. There have been no examinations or audits with respect to any taxes or tax returns of the Company, by any applicable federal, state, county, local or foreign governmental agency, and the Company has not received written notice of an intent to commence any such examination or audit that remains outstanding. The Company has duly and timely filed all income or other material tax returns required to have been filed by it, and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year.\n\nInsurance\n\n. The Company has the insurance policies set forth in", "position": 60231, "entities": [{"text": "Company", "label": "ORG", "start": 125, "end": 132}, {"text": "Company", "label": "ORG", "start": 147, "end": 154}, {"text": "the Employee Retirement Income Security Act", "label": "ORG", "start": 210, "end": 253}, {"text": "1974", "label": "DATE", "start": 257, "end": 261}, {"text": "Company", "label": "ORG", "start": 289, "end": 296}, {"text": "6", "label": "CARDINAL", "start": 466, "end": 467}, {"text": "ERISA", "label": "ORG", "start": 485, "end": 490}, {"text": "Company", "label": "ORG", "start": 864, "end": 871}, {"text": "Company", "label": "ORG", "start": 1017, "end": 1024}, {"text": "Company", "label": "ORG", "start": 1132, "end": 1139}, {"text": "Company", "label": "ORG", "start": 1278, "end": 1285}], "key_terms": ["6", "2.16", "1974"], "title": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Company participates in or contributes to, which is subject to the Employee Retirement Income Security Act of 1974, as amended (\u201cERISA\u201d). The Company has made all required contributions and has no liability to any such employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and has complied in all material respects with all applicable laws for any such employee benefit plan.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["Unilateral investor board appointments", "No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 23, "type": "Board Control", "text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "full_text": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could reasonably be expected to have a Material Adverse Effect. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.\n\nCorporate Documents\n\n. The Certificate of Incorporation and Bylaws of the Company as of the date of this Agreement are in the form made available to the Purchasers. The copy of the minute books of the Company made available to the Purchasers contains minutes of all meetings of directors and stockholders and all actions by written consent without a meeting by the directors and stockholders since the date of incorporation and accurately reflects in all material respects all actions by the directors (and any committee of directors) and stockholders. \n\n[Real Property Holding Corporation\n\n. The Company is not now and has never been a \u201cUnited States real property holding corporation\u201d as defined in the Code and any applicable regulations promulgated thereunder. The Company has filed with the Internal Revenue Service all statements, if any, with its United States income tax returns which are required under such regulations.]\n\n[Environmental and Safety Laws\n\n. Except as could not reasonably be expected to have a Material Adverse Effect [to the best of its knowledge] (a)\u00a0the Company is and has been in compliance with all Environmental Laws; (b)\u00a0there has been no release or [to the Company\u2019s knowledge] threatened release of any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum or any fraction thereof (each a \u201cHazardous Substance\u201d), on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c)\u00a0there have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included in any published U.S. federal, state or local \u201csuperfund\u201d site list or any other similar list of hazardous or toxic waste sites published by any governmental authority in the United States; and (d)\u00a0there are no underground storage tanks located on, no polychlorinated biphenyls (\u201cPCBs\u201d) or PCB-containing equipment used or stored on, and no hazardous waste as defined by the Resource Conservation and Recovery Act, as amended, stored on, any site owned or operated by the Company, except for the storage of hazardous waste in compliance with Environmental Laws. The Company has made available to the Purchasers true and complete copies of all material environmental records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and environmental studies or assessments. For purposes of this", "position": 63561, "entities": [{"text": "The Certificate of Incorporation and Bylaws of the Company", "label": "ORG", "start": 461, "end": 519}, {"text": "Purchasers", "label": "ORG", "start": 591, "end": 601}, {"text": "Purchasers", "label": "ORG", "start": 669, "end": 679}, {"text": "Real Property Holding Corporation", "label": "ORG", "start": 994, "end": 1027}, {"text": "Company", "label": "ORG", "start": 1207, "end": 1214}, {"text": "the Internal Revenue Service", "label": "ORG", "start": 1230, "end": 1258}, {"text": "Company", "label": "ORG", "start": 1520, "end": 1527}, {"text": "Company", "label": "ORG", "start": 1913, "end": 1920}, {"text": "Hazardous Substances", "label": "ORG", "start": 1945, "end": 1965}, {"text": "Company", "label": "ORG", "start": 1983, "end": 1990}], "key_terms": ["2.18"], "title": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.", "risk_level": "High", "confidence": 0.7, "explanation": "Founders lose control of the company. Investors can make unilateral decisions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 27, "type": "Voting Rights", "text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "full_text": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]\n\n[Preclinical Development and Clinical Trials. The studies, tests, preclinical development and clinical trials, if any, conducted by or on behalf of the Company are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable laws and regulations, including the Federal Food, Drug, and Cosmetic Act and 21 C.F.R. parts 50, 54, 56, 58, [312, and 812]. The descriptions of, protocols for, and data and other results of, the studies, tests, development and trials conducted by or on behalf of the Company that have been furnished or made available to the Purchasers are accurate and complete in all material respects. The Company has not received any notices or correspondence from the U.S. Food and Drug Administration (\u201cFDA\u201d) or any other governmental entity or any institutional review board or comparable authority requiring the termination, suspension or material modification of any studies, tests, preclinical development or clinical trials conducted by or on behalf of the Company.]\n\n[FDA Approvals\n\n. (a) The Company possesses all required permits, licenses, registrations, certificates, authorizations, orders, exemptions, clearances and approvals from the appropriate federal, state or foreign regulatory authorities necessary to conduct its business [as now conducted] as required by the FDA or any other federal, state or foreign agencies or bodies engaged in the regulation of [drugs, pharmaceuticals, medical devices or biohazardous materials]. (b) The Company has not received any notice of proceedings relating to the suspension, material modification, revocation or cancellation of any such permit, license, registration, certificate, authorization, order or approval. Neither the Company nor, to the Company\u2019s knowledge, any officer, employee or agent of the Company has been convicted of any crime or engaged in any conduct that has previously caused or would reasonably be expected to result in (i) debarment by the FDA under 21 U.S.C. Sections 335a, or disqualification under any similar law, rule or regulation of any other governmental entities, (ii) debarment, suspension, or exclusion under any federal healthcare programs or by the General Services Administration, or (iii) exclusion under 42 U.S.C.", "position": 76880, "entities": [{"text": "1950", "label": "DATE", "start": 45, "end": 49}, {"text": "DPA", "label": "ORG", "start": 116, "end": 119}, {"text": "DPA", "label": "ORG", "start": 274, "end": 277}, {"text": "2", "label": "CARDINAL", "start": 323, "end": 324}, {"text": "31", "label": "CARDINAL", "start": 342, "end": 344}, {"text": "C.F.R.", "label": "ORG", "start": 345, "end": 351}, {"text": "800", "label": "CARDINAL", "start": 357, "end": 360}, {"text": "DPA", "label": "ORG", "start": 497, "end": 500}, {"text": "Preclinical Development and Clinical Trials", "label": "ORG", "start": 589, "end": 632}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Company", "label": "ORG", "start": 997, "end": 1004}, {"text": "the Federal Food, Drug", "label": "ORG", "start": 1056, "end": 1078}, {"text": "21", "label": "CARDINAL", "start": 1101, "end": 1103}, {"text": "C.F.R.", "label": "ORG", "start": 1104, "end": 1110}, {"text": "50,", "label": "DATE", "start": 1117, "end": 1120}, {"text": "54", "label": "DATE", "start": 1121, "end": 1123}, {"text": "56", "label": "DATE", "start": 1125, "end": 1127}, {"text": "58", "label": "DATE", "start": 1129, "end": 1131}, {"text": "312", "label": "CARDINAL", "start": 1134, "end": 1137}, {"text": "812", "label": "CARDINAL", "start": 1143, "end": 1146}, {"text": "Company", "label": "ORG", "start": 1292, "end": 1299}, {"text": "Purchasers", "label": "ORG", "start": 1350, "end": 1360}, {"text": "the U.S. Food and Drug Administration", "label": "ORG", "start": 1477, "end": 1514}, {"text": "FDA", "label": "ORG", "start": 1517, "end": 1520}, {"text": "FDA Approvals\n\n", "label": "ORG", "start": 1788, "end": 1803}], "key_terms": ["721", "31", "1950", "800", "2"], "title": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operation, maintenance, supply, manufacture, or servicing of \u201ccovered investment critical infrastructure\u201d within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c) the maintenance or collection, directly or indirectly, of \u201csensitive personal data\u201d of U.S. citizens within the meaning of the DPA. [The Company has no current intention of engaging in such activities in the future.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 34, "type": "Voting Rights", "text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "full_text": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.\n\nConsent to Electronic Notice. Each Purchaser consents to the delivery of any stockholder notice pursuant to the DGCL, as amended or superseded from time to time, by electronic mail pursuant to", "position": 106745, "entities": [{"text": "6.6", "label": "CARDINAL", "start": 8, "end": 11}, {"text": "Company", "label": "ORG", "start": 39, "end": 46}, {"text": "Purchaser", "label": "ORG", "start": 180, "end": 189}, {"text": "Exhibit", "label": "PERSON", "start": 287, "end": 294}, {"text": "Purchaser", "label": "ORG", "start": 353, "end": 362}], "key_terms": ["6.6"], "title": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Address]. If notice is given to any Purchaser, a copy (which copy shall not constitute notice) shall also be sent to any \u201ccc\u201d address noted on Exhibit\u00a0A for such Purchaser.", "risk_level": "High", "confidence": 0.7, "explanation": "This Voting Rights clause contains unfavorable terms that significantly impact founder rights and equity.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}, {"id": 36, "type": "Voting Rights", "text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "full_text": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.\n\nSeverability\n\n. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.\n\nDelays or Omissions\n\n. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.\n\nEntire Agreement\n\n. This Agreement (including the Exhibits hereto), the Restated Certificate and the other Transaction Agreements and any Side Letters constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties are expressly canceled. \n\n[Corporate Securities Law\n\n. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF FINANCIAL PROTECTION AND INNOVATION OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY", "position": 111247, "entities": [{"text": "Purchasers", "label": "ORG", "start": 39, "end": 49}, {"text": "transferee", "label": "CARDINAL", "start": 59, "end": 69}, {"text": "Shares", "label": "PERSON", "start": 77, "end": 83}, {"text": "the Common Stock", "label": "ORG", "start": 88, "end": 104}, {"text": "Exhibits", "label": "PERSON", "start": 1453, "end": 1461}, {"text": "the Restated Certificate", "label": "ORG", "start": 1471, "end": 1495}, {"text": "Transaction Agreements", "label": "ORG", "start": 1510, "end": 1532}, {"text": "Side Letters", "label": "ORG", "start": 1541, "end": 1553}], "key_terms": ["6.10"], "title": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each future holder of all such securities, and the Company.", "risk_level": "High", "confidence": 0.7, "explanation": "Investor approval required for: company sale. Review if scope is appropriate - should be limited to major corporate actions.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}]}, "regulatory": {"count": 5, "severity": "High", "clauses": [{"id": 8, "type": "IP Assignment", "text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "position": 17444, "entities": [{"text": "Affiliates", "label": "ORG", "start": 37, "end": 47}, {"text": "Purchaser", "label": "ORG", "start": 112, "end": 121}, {"text": "Company", "label": "ORG", "start": 131, "end": 138}, {"text": "Convertible Securities", "label": "ORG", "start": 350, "end": 372}, {"text": "Convertible Securities", "label": "ORG", "start": 391, "end": 413}, {"text": "[", "label": "MONEY", "start": 700, "end": 701}, {"text": "the Initial Closing", "label": "ORG", "start": 739, "end": 758}, {"text": "Convertible Securities", "label": "ORG", "start": 764, "end": 786}, {"text": "Convertible Security Shares", "label": "ORG", "start": 1002, "end": 1029}, {"text": "Affiliate", "label": "ORG", "start": 1277, "end": 1286}, {"text": "Person", "label": "PERSON", "start": 1325, "end": 1331}, {"text": "Person", "label": "PERSON", "start": 1444, "end": 1450}, {"text": "one", "label": "CARDINAL", "start": 1661, "end": 1664}, {"text": "Board of Directors", "label": "ORG", "start": 1816, "end": 1834}, {"text": "the Company\u2019s Board of Directors", "label": "ORG", "start": 1842, "end": 1874}, {"text": "the Internal Revenue Code of", "label": "ORG", "start": 1890, "end": 1918}, {"text": "1986", "label": "DATE", "start": 1919, "end": 1923}, {"text": "Intellectual Propert", "label": "PERSON", "start": 1980, "end": 2000}], "key_terms": ["1986", "1.3", "1"], "title": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "No carve-out for prior inventions"], "specific_terms": []}, {"id": 18, "type": "IP Assignment", "text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "full_text": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.\n\nLitigation\n\n. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company\u2019s knowledge, currently threatened (i) against the Company or any Officer or director of the Company arising out of their employment or Board of Directors relationship with the Company; (ii) to the Company\u2019s knowledge, that questions the validity of the Transaction Agreements or the right of the Company to enter into them, or to consummate the transactions contemplated by the Transaction Agreements; or (iii) that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither the Company nor, to the Company\u2019s knowledge, any of its Officers or directors is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of Officers or directors, such as would affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company\u2019s employees, their services provided in connection with the Company\u2019s business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers.\n\nIntellectual Property.\n\nThe Company owns, possesses, has developed, or has acquired on commercially reasonable terms, legal rights to all Company Intellectual Property sufficient to carry out its business as now conducted; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nNo past or current product or service or activity of the Company has infringed or violated, or infringes or otherwise violates any Intellectual Property Rights of a third Person; provided that the foregoing representation is made to the Company\u2019s knowledge [with respect to patents and trademarks]. \n\nTo the Company\u2019s knowledge, by conducting the Company\u2019s business as currently conducted or as presently proposed, the Company would not infringe or violate any of the Intellectual Property Rights of a third Person. The Company has not received any unsolicited offers to license any Intellectual Property Rights from any third Person. \n\nTo the Company\u2019s knowledge, no third Person is presently infringing any Company-Controlled Intellectual Property in a way that is expected to have a Material Adverse Effect.\n\nOther than pursuant to: (i) standard end-user license or services agreements for the Company\u2019s products and services on substantially the Company\u2019s standard forms made available to the Purchasers; (ii) customary nondisclosure agreements entered into by the Company in the ordinary course of business (that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights); (iii) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (iv) licenses to a service provider solely for the purpose of allowing such service provider to provide services to the Company (collectively, \u201cStandard Outbound Agreements\u201d), the Company has not granted to a third Person any options, licenses, covenants not to assert, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company-Controlled Intellectual Property that are material to the Company\u2019s business as now conducted. \n\nOther than pursuant to: (i)\u00a0standard license or services agreements for commercially available software products and cloud services non-exclusively licensed to Company under standard terms[, which products and cloud services are not incorporated into the Company\u2019s products or services]; (ii) backup licenses from employees and contractors granted in connection with providing services to the Company; (iii) licenses to Open Source Software; (iv) customary nondisclosure agreements entered into by the Company in the ordinary course of business that do not include any terms (w) granting the right to use residuals, (x) assigning Intellectual Property Rights, (y) granting express license rights, or (z) constituting a covenant not to assert Intellectual Property Rights; (v) nonexclusive feedback licenses and nonexclusive licenses to use trademarks, in each case that are incidental to the subject matter of the applicable agreement in which they are incorporated; and (vi) licenses to the Company solely for the purpose of enabling the Company to provide services to the licensor (collectively, \u201cStandard Inbound Agreements\u201d), the Company is not bound by or a party to any options, licenses, covenants not to assert or other grants or agreements of any kind with respect to Intellectual Property Rights of any third Person that are material to the Company\u2019s business as now conducted. \n\nThe Company has taken commercially reasonable measures to maintain and protect all confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret. To the Company\u2019s knowledge, [except as would not reasonably be expected to result in a Material Adverse Effect], there has been no unlawful, accidental or unauthorized access to or use or disclosure of any confidential information and trade secrets of the Company that the Company intended to maintain as confidential or a trade secret.\n\n(i) Each current and former employee of the Company has assigned to the Company all Intellectual Property Rights that such employee has solely or jointly conceived, reduced to practice, developed, or made during the period of employment with the Company that: (A) relate, at the time of conception, reduction to practice, development, or making of such Intellectual Property Right, to the Company\u2019s business as then conducted or as then proposed to be conducted; (B) were developed on any amount of the Company\u2019s time or with the use of any of the Company\u2019s equipment, supplies, facilities or information; or (C) resulted from such individual\u2019s performance of services for the Company. (ii) Each current and former consultant of the Company who was involved in the development of any [material] Intellectual Property Rights for the Company or that are otherwise owned or purported to be owned by the Company has assigned to the Company all Intellectual Property Rights that such consultant has solely or jointly conceived, reduced to practice, developed, or made during the period of its consulting relationship with the Company that resulted from such consultant\u2019s performance of services for the Company. (iii) Each such employee and consultant has executed an agreement with the Company regarding confidentiality and proprietary information, and assignment of Intellectual Property Rights developed by or for the Company, [substantially] in the form or forms made available to the Purchasers or their respective counsel (the \u201cConfidential Information Agreements\u201d). (iv) No such employee or consultant has excluded Intellectual Property Rights from the assignment of Intellectual Property Rights pursuant to such Person\u2019s Confidential Information Agreement, which excluded Intellectual Property Rights would be material to the Company in the conduct of the Company\u2019s business as now conducted or currently proposed to be conducted. (v) The Company is not aware that any current or former employee or consultant is in violation of any Confidential Information Agreement. \n\nThe Company has not embedded, used, linked or distributed any open source, software, technologies or other materials that are licensed or distributed under any license arrangement or other distribution model qualifying for the \u201cOpen Source\u201d definition promulgated by the Open Source Initiative at www.opensource.org/osd or any other public domain or \u201ccommunity\u201d (or similar) materials (collectively \u201cOpen Source Software\u201d) in connection with any of its products or services or proprietary materials in any manner that requires, or purports to require, (i)\u00a0any material software code owned or authored by or on behalf of the Company (\u201cCompany Code\u201d) to be disclosed or distributed in source code form or be licensed for the purpose of making derivative works; (ii)\u00a0any restriction on the consideration to be charged for the distribution of any such Company Code; (iii)\u00a0the grant to any third Person of any rights or immunities under material Company-Controlled Intellectual Property; or (iv)\u00a0any other material limitation, restriction or condition on the right of the Company with respect to its use or distribution of any material Company-Controlled Intellectual Property (other than attribution, warranty and liability disclaimer, and notice delivery conditions). The Company is in [material] compliance with all licenses for Open Source Software that it embeds, links to, uses or distributes. \n\nNo government funding, facilities of a university, college, hospital, foundation, other educational institution or research center, or other funding from third Persons provided specifically for research and development was used in the development of any Company-Controlled Intellectual Property in a manner that has resulted in such entity retaining any claim of ownership or right to use any such Company-Controlled Intellectual Property. To the Company\u2019s knowledge, no Person who was involved in, or who contributed to, the creation or development of any Company-Controlled Intellectual Property, has performed services for the government, university, college, hospital, foundation, or other educational institution or research center in a manner that would affect Company\u2019s rights in the Company-Controlled Intellectual Property.\n\n[Generative AI. (i) The Company uses all Generative AI Tools (as defined below) in [material] compliance with the applicable license terms, consents, agreements and laws. (ii) The Company has not included and does not include any sensitive Personal Information, trade secrets or material confidential or proprietary information of the Company, or of any third Person under an obligation of confidentiality by the Company, in any prompts or inputs into any Generative AI Tools, except in cases where such Generative AI Tools do not use such information, prompts or services to train the machine learning or algorithm of such tools or improve the services related to such tools. (iii) The Company has not used Generative AI Tools to develop any material Company-Controlled Intellectual Property that the Company intended to maintain as proprietary in a manner that it believes would materially affect the Company\u2019s ownership or rights therein. (iv) For purposes hereof, \u201cGenerative AI Tools\u201d means generative artificial intelligence technology or similar tools capable of automatically producing various types of content (such as source code, text, images, audio, and synthetic data) based on user-supplied prompts.]\n\nCompliance with Other Instruments\n\n. The Company is not in violation or default (a) of any provisions of its Certificate of Incorporation or Bylaws; (b) in any material respect of any instrument, judgment, order, writ or decree; (c) in any material respect under any note, indenture or mortgage; (d) in any material respect under any lease, agreement, contract or purchase order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule; or (e) of any provision of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture, or nonrenewal of any material permit or license applicable to the Company.\n\nAgreements; Actions.\n\nExcept for the Transaction Agreements, there are no agreements, understandings, instruments, contracts or proposed transactions to which the Company is a party or by which it is bound that involve (i)\u00a0obligations (contingent or otherwise) of, or payments to, the Company in excess of $[__________] (other than employment agreements and offer letters); (ii) other than pursuant to any university licenses listed in Section [2.8(f) and/or 2.8(j)] of the Disclosure Schedule, the grant of rights to manufacture, produce, assemble, license, market, or sell its products to any other Person that limit the Company\u2019s exclusive right to develop, manufacture, assemble, distribute, market or sell its products; or (iii) any \u201cmost favored\u201d provisions, Board of Directors observer rights, or other side letter agreements not otherwise disclosed pursuant to any other representation.\n\nThe Company has not (i)\u00a0declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii)\u00a0incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of [__________] or in excess of [__________] in the aggregate, (iii)\u00a0made any loans or advances to any Person, other than ordinary advances for business expenses, or (iv)\u00a0sold, exchanged or otherwise disposed of any material portion of its assets or rights, other than in the ordinary course of business. For the purposes of (a) and (b) of this", "position": 34236, "entities": [{"text": "3", "label": "CARDINAL", "start": 8, "end": 9}, {"text": "the Restated Certificate", "label": "ORG", "start": 359, "end": 383}, {"text": "Company", "label": "ORG", "start": 740, "end": 747}, {"text": "Board of Directors", "label": "ORG", "start": 825, "end": 843}, {"text": "Company", "label": "ORG", "start": 866, "end": 873}, {"text": "Company", "label": "ORG", "start": 986, "end": 993}, {"text": "Company", "label": "ORG", "start": 1589, "end": 1596}, {"text": "Company", "label": "ORG", "start": 1618, "end": 1625}, {"text": "Company", "label": "ORG", "start": 1806, "end": 1813}], "key_terms": ["2.8", "3"], "title": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for [(i) the filing of the Restated Certificate, which will have been filed as of the [Initial] Closing, and (ii)] filings pursuant to applicable securities laws, which have been made or will be made in a timely manner.", "risk_level": "High", "confidence": 0.9, "explanation": "OVERLY BROAD: This IP assignment clause captures ALL intellectual property and inventions, including prior work and side projects. The actual language states you assign everything to the company, which could prevent you from using your own prior inventions or working on unrelated projects. This limits future opportunities if this venture fails.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit", "All IP assigned - includes prior work", "Side projects may be claimed by company", "Limits future ventures"], "specific_terms": []}, {"id": 35, "type": "IP Assignment", "text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "full_text": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing. \n\nNo Finder\u2019s Fees\n\n. Each party represents that it neither is nor will be obligated for any finder\u2019s fee or commission in connection with this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which each Purchaser or any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless each Purchaser from any liability for any commission or compensation in the nature of a finder\u2019s or broker\u2019s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.\n\nFees and Expenses\n\n. Within five business days after the later of (a) the receipt of a summary invoice therefor or (b) the Initial Closing, the Company shall pay the reasonable fees and expenses of [_______], the counsel for [name of lead Purchaser], in an amount not to exceed, in the aggregate, $[________]; provided, however, that notwithstanding the foregoing [name of lead Purchaser] may pay such amount directly to [name of Investor\u2019s counsel] at the Initial Closing and such amount shall be deducted from and credited against [name of lead Purchaser]\u2019s purchase price and deemed paid directly to the Company and then further remitted to [name of Investor\u2019s counsel].\n\nCosts of Enforcement\n\n. [If any action at law or in equity (including, arbitration) is necessary to enforce or interpret the terms of any of the Transaction Agreements, the prevailing party shall be entitled to reasonable attorneys\u2019 fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.] [Each party will bear its own costs in respect of any disputes arising under this Agreement.]\n\nAmendments and Waivers\n\n. Except as otherwise specifically set forth in this Agreement, any term of this Agreement may be amended, terminated or waived only with the written consent of the Company and [(i)] the holders of at least [specify percentage] of the then-outstanding Shares[, or (ii) for an amendment, termination or waiver effected prior to the Initial Closing, Purchasers obligated to purchase [specify percentage] of the Shares to be issued at the Initial Closing][; provided, however, that any provision of this Agreement may be waived by any waiving party on such party\u2019s own behalf, without the consent of any other party]. Notwithstanding the foregoing or anything herein to the contrary, no amendment, termination or waiver of any provision of this Agreement effected without the consent of a Purchaser shall be effective against such Purchaser unless such amendment, termination, or waiver applies to all Purchasers in the same fashion.  The Company shall give prompt written notice of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto; provided that the failure to provide such notice shall not invalidate any amendment, termination or waiver hereunder.  Any amendment or waiver effected in accordance with this", "position": 107256, "entities": [{"text": "Purchaser\u2019s", "label": "ORG", "start": 94, "end": 105}, {"text": "Exhibit", "label": "PERSON", "start": 136, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 834, "end": 843}, {"text": "Company", "label": "ORG", "start": 1504, "end": 1511}, {"text": "five business days", "label": "DATE", "start": 1610, "end": 1628}, {"text": "the Initial Closing", "label": "ORG", "start": 1701, "end": 1720}, {"text": "[", "label": "MONEY", "start": 1880, "end": 1881}, {"text": "Purchaser", "label": "ORG", "start": 1960, "end": 1969}], "key_terms": ["232"], "title": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as updated from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided, and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 37, "type": "IP Assignment", "text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "full_text": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]\n\nTermination of Closing Obligations\n\n. Each Purchaser shall have the right to terminate its obligations to complete the [Initial] Closing [or any subsequent Closing, as the case may be,] if prior to the occurrence thereof, any of the following occurs:\n\nthe Company consummates a Deemed Liquidation Event (as defined in the Restated Certificate);\n\nthe closing of an initial public offering of the Company, in which case the Purchasers may terminate their obligations hereunder immediately prior to, or contingent upon, such closing; or\n\nthe Company (i) applies for or consents to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (ii) becomes subject to the appointment of a receiver, trustee, custodian or liquidator of itself or substantially all of its property, (iii) makes an assignment for the benefit of creditors, (iv) institutes any proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, or files a petition or answer seeking reorganization or an arrangement with creditors to take advantage of any insolvency law, or files an answer admitting the material allegations of a bankruptcy, reorganization or insolvency petition filed against it, or (v) becomes subject to any involuntary proceedings under the United States Bankruptcy Code or any other federal or state bankruptcy, reorganization, receivership, insolvency or other similar law affecting the rights of creditors generally, when proceeding is not dismissed within 30 days of filing, or have an order for relief entered against it in any proceedings under the United States Bankruptcy Code.\n\nDispute Resolution\n\n.\n\n[Alternative 1: Except as (i)\u00a0otherwise provided in this Agreement, or (ii)\u00a0any disputes, controversies, or claims arising out of either party\u2019s intellectual property rights for which a provisional remedy or equitable relief is sought, any unresolved dispute, controversy, or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation, or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved by arbitration before a single arbitrator. Such arbitrator shall be mutually agreed upon by the parties, and if no agreement can be reached within 30 days after names of potential arbitrators have been proposed by Judicial Arbitration and Mediation Services, Inc. (\u201cJAMS\u201d), then JAMS shall choose one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement. The arbitration shall take place in [location], pursuant to the JAMS Comprehensive Arbitration Rules and Procedures [and in accordance with the Expedited Procedures in those rules] [or pursuant to JAMS\u2019 Streamlined Arbitration Rules and Procedures]; provided, however, that there shall be limited discovery prior to the arbitration hearing as follows: (x) exchange of witness lists and copies of documentary evidence and documents relating to the issues to be arbitrated, (y)\u00a0depositions of all party witnesses, and (z) such other depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the [state] Code of Civil Procedure, the arbitrator shall be required to provide in writing to the parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Judgment on the award may be entered in any court having jurisdiction.] \n\n[Alternative 2: The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of [state] and to the jurisdiction of the United States District Court for the District of [judicial district] for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of [state] or the United States District Court for the District of [judicial district], and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.] \n\nEach of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of [_____] or any state court of [state] having subject matter jurisdiction. \n\nWaiver of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION AGREEMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.\n\n[No Commitment for Additional Financing\n\n. The Company acknowledges and agrees that no Purchaser has made any representation, undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Shares as set forth herein and subject to the conditions set forth herein. In addition, the Company acknowledges and agrees that (i)\u00a0no statements, whether written or oral, made by any Purchaser or its representatives on or after the date of this Agreement shall create an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment, (ii)\u00a0the Company shall not rely on any such statement by any Purchaser or its representatives, and (iii) an obligation, commitment or agreement to provide or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Purchaser and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties intend for such writing to be a binding obligation or agreement. Each Purchaser shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance.] \n\n[Waiver of Conflicts\n\n. Each party to this Agreement acknowledges that [insert name of Company counsel], counsel for the Company, may have in the past performed, and may continue to or in the future perform, legal services for certain of the Purchasers in matters that are similar, but not substantially related, to the transactions described in this Agreement, including the representation of such Purchasers in venture capital financings and other matters. Accordingly, each party to this Agreement hereby acknowledges that (a) they have had an opportunity to ask for information relevant to this disclosure, and (b) [insert name of Company counsel] represents only the Company with respect to the Agreement and the transactions contemplated hereby. The Company gives its informed consent to [insert name of Company counsel]\u2019s existing and/or future representation of such Purchasers in matters not substantially related to this Agreement, and such Purchasers give their informed consent to [insert name of Company counsel]\u2019s representation of the Company in connection with this Agreement and the transactions contemplated hereby.]\n\n[Signature Page Follows]\n\nIN WITNESS WHEREOF, the parties have executed this Series\u00a0[___] Preferred Stock Purchase Agreement as of the date first written above.\n\nCOMPANY:\t[Insert Company Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nAddress:\t\t\n\t\n\nEmail:\t \n\nPURCHASER:\t[Insert Investor Name]\n\nBy:\t\t\n\nName:\t\t\n\nTitle:\t\t\n\nSCHEDULE OF PURCHASERS\n\n[[Alternative if there is a mandatory tranche closing:\n\n]]\n\nEXHIBIT A-1\n\nSCHEDULE OF NON-SIGNING HOLDERS OF CONVERTIBLE SECURITIES\n\nFORM OF AMENDED AND RESTATED\nCERTIFICATE OF INCORPORATION\n\nDISCLOSURE SCHEDULE\n\n[This Disclosure Schedule is made and given pursuant to", "position": 113471, "entities": [{"text": "25102", "label": "DATE", "start": 15, "end": 20}, {"text": "25105", "label": "DATE", "start": 24, "end": 29}, {"text": "THE CALIFORNIA CORPORATIONS CODE", "label": "ORG", "start": 33, "end": 65}, {"text": "Closing", "label": "PERSON", "start": 364, "end": 371}, {"text": "the Restated Certificate", "label": "ORG", "start": 526, "end": 550}, {"text": "Company", "label": "ORG", "start": 603, "end": 610}, {"text": "Purchasers", "label": "ORG", "start": 630, "end": 640}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1128, "end": 1161}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1625, "end": 1658}, {"text": "30 days", "label": "DATE", "start": 1848, "end": 1855}, {"text": "the United States Bankruptcy Code", "label": "ORG", "start": 1939, "end": 1972}, {"text": "Insert Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Insert Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": ["25105", "25102", "1", "30", "25100"], "title": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "financial": {"count": 7, "severity": "High", "clauses": [{"id": 15, "type": "Conversion Rights", "text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "position": 27793, "entities": [{"text": "Company", "label": "ORG", "start": 87, "end": 94}, {"text": "Common Stock", "label": "ORG", "start": 259, "end": 271}, {"text": "Common Stock", "label": "ORG", "start": 311, "end": 323}, {"text": "Common Stock", "label": "ORG", "start": 373, "end": 385}, {"text": "Preferred Stock", "label": "ORG", "start": 469, "end": 484}, {"text": "Shares", "label": "ORG", "start": 597, "end": 603}, {"text": "Sections 2.2(a)(ii", "label": "ORG", "start": 759, "end": 777}, {"text": "2.2(b", "label": "CARDINAL", "start": 783, "end": 788}, {"text": "Company", "label": "ORG", "start": 1065, "end": 1072}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1087, "end": 1118}, {"text": "Common Stock or Preferred Stock", "label": "ORG", "start": 1185, "end": 1216}, {"text": "Common Stock", "label": "ORG", "start": 1244, "end": 1256}, {"text": "Common Stock", "label": "ORG", "start": 1275, "end": 1287}, {"text": "Company", "label": "ORG", "start": 1379, "end": 1386}, {"text": "less than 180 days", "label": "DATE", "start": 1522, "end": 1540}, {"text": "Company", "label": "ORG", "start": 1555, "end": 1562}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 1637, "end": 1675}], "key_terms": ["2.2", "4"], "title": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 29, "type": "Conversion Rights", "text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "full_text": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser\u2019s representations as expressed herein. The Purchaser understands that the Shares are \u201crestricted securities\u201d under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Shares, or the Common Stock into which it may be converted, for resale except as set forth in the Investors\u2019 Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of the Purchaser\u2019s control, and which the Company is under no obligation and may not be able to satisfy. [The Purchaser acknowledges that the Company filed a registration statement for a public offering of its Common Stock, which was withdrawn effective [_____ __, 20_]. The Purchaser understands that this offering is not intended to be part of the public offering, and that the Purchaser will not be able to rely on the protection of", "position": 89443, "entities": [{"text": "Purchasers", "label": "ORG", "start": 48, "end": 58}, {"text": "Purchaser", "label": "ORG", "start": 106, "end": 115}, {"text": "Shares", "label": "ORG", "start": 137, "end": 143}, {"text": "Purchaser", "label": "ORG", "start": 412, "end": 421}, {"text": "Purchaser", "label": "ORG", "start": 465, "end": 474}, {"text": "Shares", "label": "ORG", "start": 496, "end": 502}, {"text": "Purchaser", "label": "ORG", "start": 625, "end": 634}, {"text": "Shares", "label": "ORG", "start": 649, "end": 655}, {"text": "the Securities and Exchange Commission", "label": "ORG", "start": 701, "end": 739}, {"text": "Company", "label": "ORG", "start": 896, "end": 903}, {"text": "Shares", "label": "ORG", "start": 949, "end": 955}, {"text": "the Common Stock", "label": "ORG", "start": 960, "end": 976}, {"text": "Purchaser", "label": "ORG", "start": 1080, "end": 1089}, {"text": "Shares", "label": "ORG", "start": 1314, "end": 1320}, {"text": "Company", "label": "ORG", "start": 1358, "end": 1365}, {"text": "Purchaser\u2019s", "label": "ORG", "start": 1391, "end": 1402}, {"text": "Company", "label": "ORG", "start": 1426, "end": 1433}, {"text": "Company", "label": "ORG", "start": 1526, "end": 1533}, {"text": "Common Stock", "label": "ORG", "start": 1594, "end": 1606}, {"text": "20", "label": "CARDINAL", "start": 1649, "end": 1651}, {"text": "Purchaser", "label": "ORG", "start": 1659, "end": 1668}, {"text": "Purchaser", "label": "ORG", "start": 1764, "end": 1773}], "key_terms": ["2", "20"], "title": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 30, "type": "Liquidation Preference", "text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "position": 91263, "entities": [{"text": "Purchaser", "label": "ORG", "start": 60, "end": 69}, {"text": "Shares", "label": "ORG", "start": 123, "end": 129}, {"text": "Company", "label": "ORG", "start": 144, "end": 151}, {"text": "Shares", "label": "ORG", "start": 220, "end": 226}, {"text": "Purchaser", "label": "ORG", "start": 244, "end": 253}, {"text": "Shares", "label": "ORG", "start": 275, "end": 281}, {"text": "Shares", "label": "ORG", "start": 342, "end": 348}, {"text": "one", "label": "CARDINAL", "start": 370, "end": 373}, {"text": "1933", "label": "DATE", "start": 492, "end": 496}, {"text": "SALE", "label": "ORG", "start": 587, "end": 591}, {"text": "DISTRIBUTION THEREOF", "label": "PERSON", "start": 595, "end": 615}, {"text": "1933", "label": "DATE", "start": 840, "end": 844}, {"text": "Transaction Agreements", "label": "ORG", "start": 899, "end": 921}, {"text": "Shares", "label": "ORG", "start": 1026, "end": 1032}, {"text": "Purchaser", "label": "ORG", "start": 1132, "end": 1141}, {"text": "Purchaser", "label": "ORG", "start": 1277, "end": 1286}], "key_terms": ["501", "1933", "11"], "title": "Section 11 of the Securities Act.]", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u26a1 Moderate Risk: Agreement has 19 areas needing negotiation. Generally acceptable with modifications."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 54% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}, {"period": "2-3 years", "risks": [{"title": "Loss of Economic Value", "probability": 82, "impact": "Critical", "description": "3x participating liquidation preference means in most exits, founders receive <10% of what their equity percentage suggests."}, {"title": "IP Ownership Disputes", "probability": 35, "impact": "Medium", "description": "Broad IP assignment could create disputes if founders want to start new ventures in similar space."}]}, {"period": "3+ years", "risks": [{"title": "Future Venture Limitations", "probability": 30, "impact": "Medium", "description": "If company fails, inability to reuse technology or ideas could limit opportunities for next startup."}]}], "overall_outlook": {"probability": 54, "sentiment": "Unfavorable", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 54% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 8, "priority": "Critical", "clause": "IP Assignment (5 instances found)", "clause_snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby a", "full_text": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchaser shall cooperate in good faith to reduce or eliminate any such withholding.]\n\nThe Company and each Purchaser holding a Convertible Security hereby agree[, on behalf of themselves and all holders of Convertible Securities,] that [such/all] Convertible Securities hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Convertible Security Shares, to fix the conversion price (as defined therein) at $[___] per share, and, immediately upon the Initial Closing, all Convertible Securities shall be deemed terminated in full and null, void and of no further force or effect; provided that the foregoing will not impair the right of the holder of a Convertible Security to receive the applicable number of Convertible Security Shares shown opposite such holder\u2019s name on Exhibit\u00a0A-1.\n\nDefined Terms Used in this Agreement\n\n. In addition to the terms defined above, the following terms used in this Agreement shall be construed to have the meanings set forth or referenced below.\n\n\u201cAffiliate\u201d means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or any venture capital fund or investment fund now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person.\n\n\u201cBoard of Directors\u201d means the Company\u2019s Board of Directors.\n\n\u201cCode\u201d means the Internal Revenue Code of 1986, as amended.\n\n\u201cCompany Intellectual Property\u201d means all Intellectual Property Rights that are owned, purported to be owned by, or in-licensed to the Company, or used by the Company in the conduct of the Company\u2019s business as now conducted.\n\n\u201cCompany-Controlled Intellectual Property\u201d means (i) Intellectual Property Rights owned or purported to be owned by the Company and (ii) Intellectual Property Rights exclusively in-licensed to the Company.\n\n\u201cGAAP\u201d means generally accepted accounting principles in the United States, applied on a consistent basis throughout the periods indicated.\n\n\u201cIndemnification Agreement\u201d means the agreement between the Company and [list the individual director names], in the form of Exhibit\u00a0D attached to this Agreement.\n\n\u201cIntellectual Property Rights\u201d means all intellectual property rights, whether registered or unregistered, that are recognized in any jurisdiction of the world, including such rights in patents, utility models, trademarks and tradenames, copyrights, trade secrets, and domain names (and any registrations of or applications to register any of the foregoing).\n\n\u201cInvestors\u2019 Rights Agreement\u201d means the agreement among the Company and the Purchasers [and certain other stockholders of the Company] dated as of the date of the Initial Closing, in the form of Exhibit\u00a0E attached to this Agreement.\n\n\u201cKnowledge\u201d including the phrase \u201cto the Company\u2019s knowledge\u201d means the Knowledge Parties\u2019 actual knowledge after reasonable investigation and assuming such knowledge as the individual would have as a result of the reasonable performance of the individual\u2019s duties in the ordinary course. Additionally, for purposes of", "issue": "Overly broad IP assignment covering all intellectual property", "recommendation": "Add carve-outs for: (1) prior inventions, (2) side projects, (3) unrelated work", "negotiation_tips": ["Document what IP you're bringing to company vs creating for company", "Standard practice is to only assign IP created as part of employment/founder duties", "Offer detailed schedule of excluded IP to provide clarity and avoid future disputes", "Add provision allowing side projects in different fields with prior board approval"], "expected_impact": "Preserves ability to use prior work in future ventures if this startup fails", "risk_level": "High", "specific_concerns": ["Limits ability to work on other projects", "Prior work may be claimed by company"], "detected_terms": ["all intellectual property"], "instances": [{"id": 8, "snippet": "Section 1.3(b), the Company (and its Affiliates and agents) shall use commercially reasonable efforts to notify Purchaser, and the Company and Purchas"}, {"id": 18, "snippet": "Section\u00a03 of this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with,"}, {"id": 35, "snippet": "Section 232 of the DGCL (or any successor thereto) at the e-mail address set forth below such Purchaser\u2019s name on the signature page or Exhibit\u00a0A, as "}, {"id": 37, "snippet": "SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUAL"}, {"id": 19, "snippet": "Section\u00a02.10, all indebtedness, liabilities, agreements, understandings, instruments, contracts and proposed transactions involving the same Person (i"}]}, {"id": 10, "priority": "Critical", "clause": "Board Control (11 instances found)", "clause_snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse ef", "full_text": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially the form of Exhibit\u00a0F attached to this Agreement, dated as of the date of the applicable Closing.\n\n\u201cMaterial Adverse Effect\u201d means a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property, or results of operations of the Company.\n\n\u201cMilestones\u201d means the milestones set forth on Annex 1 to this Agreement.\n\n\u201cOfficer\u201d means the Chief Executive Officer, President, Chief Financial Officer, and any other person who reports directly to the Board of Directors or the Chief Executive Officer.\n\n\u201cPerson\u201d means any individual, corporation, partnership, trust, limited liability company, association or other entity.\n\n\u201cRequisite Purchasers\u201d means Purchasers holding [a majority] of the Shares issued pursuant to this Agreement. \n\n\u201cRight of First Refusal and Co-Sale Agreement\u201d means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the date of the Initial Closing, in the form of Exhibit\u00a0G attached to this Agreement.\n\n\u201cSecurities Act\u201d means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.\n\n\u201cSide Letters\u201d means the letter agreements listed in", "issue": "This Board Control requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Frame as risk mitigation for investor - founder-led companies perform better statistically", "Propose independent directors with relevant industry expertise as compromise", "Include founder-approval requirements (supermajority) for critical decisions like CEO removal, sale, or IP", "Show examples of successful companies that maintained founder board control"], "expected_impact": "Maintains strategic control and prevents forced exits or CEO replacement", "risk_level": "High", "specific_concerns": [], "detected_terms": ["majority"], "instances": [{"id": 10, "snippet": "Section 2.8, [specify]].\n\n\u201cManagement Rights Letter\u201d means the agreement between the Company and [name the applicable Purchasers], in substantially th"}, {"id": 13, "snippet": "Section 2.25]), the term the \u201cCompany\u201d shall include any subsidiaries of the Company, unless otherwise noted herein.\n\nOrganization, Good Standing, Cor"}, {"id": 14, "snippet": "Section 2.2(a)(i) above), (ii) options to purchase [__________] shares have been granted and are currently outstanding, and (iii) [__________] shares "}, {"id": 21, "snippet": "Section\u00a02.16(c)(i) of the Disclosure Schedule or as required by law, upon termination of the employment of any such employees, no severance or other p"}, {"id": 22, "snippet": "Section\u00a02.16(f) of the Disclosure Schedule sets forth each employee benefit plan maintained, established or sponsored by the Company, or which the Com"}, {"id": 23, "snippet": "Section 2.18 of the Disclosure Schedule and all such policies are in full force and effect.  \n\nPermits\n\n. The Company has all franchises, permits, lic"}, {"id": 1, "snippet": "Section 1.3 below], subject to adjustment of such per share amounts for stock splits, stock combinations, stock dividends, and the like that occur bet"}, {"id": 11, "snippet": "Section 2.10(a)(iii) of the Disclosure Schedule.\n\n\u201cTranche Closing Condition\u201d means the earlier to occur of: (i) the determination by [(x)] the Board "}, {"id": 28, "snippet": "Section 1320a-7 or any similar law, rule or regulation of any governmental entities. (c) Neither the Company nor any of its officers, employees, or, t"}, {"id": 31, "snippet": "Section\u00a07701(a)(30) of the Code), the Purchaser hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdicti"}, {"id": 32, "snippet": "Section\u00a02, as modified by the Disclosure Schedule, shall be true and correct in all respects as of the [Initial] Closing [and, as to any subsequent Cl"}]}, {"id": 15, "priority": "Critical", "clause": "Conversion Rights (5 instances found)", "clause_snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to ", "full_text": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including the aggregate number of shares of, or issuable pursuant to, each of the following: (i)\u00a0issued and outstanding Common Stock, including, with respect to restricted Common Stock; (ii)\u00a0outstanding stock options; (iii)\u00a0shares of Common Stock reserved for future award grants under the Stock Plan; (iv)\u00a0issued and outstanding Preferred Stock, by series; and (v)\u00a0warrants or stock purchase rights, if any.] Except for (A) the conversion privileges of the Shares to be issued under this Agreement, (B) the rights provided in Section\u00a04 of the Investors\u2019 Rights Agreement, and (C) the securities and rights described in Sections 2.2(a)(ii) and 2.2(b) of this Agreement and Section 2.2(c) of the Disclosure Schedule, there are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, to purchase or acquire from the Company any shares of Common Stock or Preferred Stock, or any securities convertible into or exchangeable for shares of Common Stock or Preferred Stock. All outstanding shares of Common Stock and all shares of Common Stock underlying outstanding options are subject to (i) a right of first refusal in favor of the Company upon any proposed transfer (other than transfers for estate planning purposes); and (ii) a lock-up or market standoff agreement of not less than 180 days following the Company\u2019s initial public offering pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act.\n\n(i) Except as described in", "issue": "This Conversion Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 15, "snippet": "Section 2.2(c) of the Disclosure Schedule sets forth the summary capitalization of the Company immediately following the [Initial] Closing including t"}, {"id": 29, "snippet": "Section 2 of this Agreement or the right of the Purchasers to rely thereon.\n\nRestricted Securities\n\n. The Purchaser understands that the Shares have n"}, {"id": 4, "snippet": "Section 1.2(c)(iv) is waived in writing by the Requisite Purchasers with respect to all Purchasers, if any Purchaser, together with such Purchaser\u2019s A"}, {"id": 5, "snippet": "Section 5.A of the Restated Certificate shall be the sole and exclusive remedy under this Agreement for the Company or any other Purchaser against any"}, {"id": 7, "snippet": "Section 1.2(c).  This Section 1.2(c) shall terminate and be of no further force and effect as of the first to occur of (i) the Outside Date, (ii) the "}]}, {"id": 17, "priority": "Critical", "clause": "Voting Rights (4 instances found)", "clause_snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in acco", "full_text": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable federal and state securities laws. The Common Stock issuable upon conversion of the Shares has been duly reserved for issuance, and upon issuance in accordance with the terms of the Restated Certificate, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable federal and state securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in Section 3 of this Agreement and in the Voting Agreement, the Common Stock issuable upon conversion of the Shares will be issued in compliance with all applicable federal and state securities laws. \n\nGovernmental Consents and Filings\n\n. Assuming the accuracy of the representations made by the Purchasers in", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 17, "snippet": "Section 3 of this Agreement and subject to the filings described in Section 2.6 below, the Shares will be issued in compliance with all applicable fed"}, {"id": 27, "snippet": "Section 721 of the Defense Production Act of 1950, as amended, including all implementing regulations thereof (the \u201cDPA\u201d); (b) the ownership, operatio"}, {"id": 34, "snippet": "Section\u00a06.6. If notice is given to the Company, a copy (which copy shall not constitute notice) shall also be sent to [Company Counsel Name and Addres"}, {"id": 36, "snippet": "Section 6.10 shall be binding upon the Purchasers and each transferee of the Shares (or the Common Stock issuable upon conversion thereof), each futur"}]}, {"id": 26, "priority": "Critical", "clause": "Representations & Warranties (4 instances found)", "clause_snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 o", "full_text": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the Small Business Investment Act of 1958, as amended (the \u201cSmall Business Act\u201d), and the regulations promulgated thereunder, including [Section 121.301 of Title 13 of the CFR][Section 107.710 of Title 13 of the CFR]. The information delivered to each Purchaser that is a licensed Small Business Investment Company (an \u201cSBIC Purchaser\u201d) on SBA Forms 480, 652 and 1031 delivered in connection herewith is true and complete. The Company is not ineligible for financing by any SBIC Purchaser pursuant to Section 107.720 of the CFR. The Company acknowledges that each SBIC Purchaser is a Federal licensee under the Small Business Act.]\n\n[Foreign Corrupt Practices Act\n\n. To the Company\u2019s knowledge, none of the Company or its subsidiaries, nor any of their directors, officers, employees or agents  (in each case, while acting in such capacities), have directly or indirectly made, offered, promised, or authorized any payment or gift of any money or anything of value to or for the benefit of any \u201cforeign official\u201d (as defined in the U.S. Foreign Corrupt Practices Act (the \u201cFCPA\u201d)), foreign political party or official thereof or candidate for foreign political office  (each, a \u201cGovernment Official\u201d) for the purpose of (i) influencing any official act or decision of such Government Official, (ii) inducing such Government Official to do or omit to do any act in violation of their lawful duty, (iii) inducing such Government Official to use their influence to affect any act or decision of a governmental authority, or (iv) securing any improper advantage, in the case of (i)-(iv) above in order to assist the Company or its subsidiaries in obtaining or retaining business for or with, or directing business to, any person. Neither the Company nor its subsidiaries, nor any of their directors, officers, employees or, to the Company\u2019s knowledge, agents  (in each case, while acting in such capacities), have made or authorized any bribe, rebate, payoff, influence payment, kickback, or other unlawful payment of funds or received or retained any funds in violation of any applicable Anti-Corruption Law (as defined below). [The Company represents that it has maintained, and has caused its subsidiaries to maintain, systems of internal controls (accounting systems, purchasing systems and billing systems) [and written policies] reasonably designed to ensure compliance with the FCPA or any other applicable anti-bribery or anti-corruption law (collectively, \u201cAnti-Corruption Laws\u201d), and reasonably designed to ensure that all books and records of the Company accurately and fairly reflect, in reasonable detail, all transactions and dispositions of funds and assets.] Neither the Company nor[, to the Company\u2019s knowledge,] any of its officers, directors, or employees, are the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to appliable Anti-Corruption Laws (\u201cEnforcement Action\u201d).]\n\nData Privacy\n\n. \n\nIn connection with the collection, storage, use, access, disclosure and/or other processing of any information that constitutes \u201cpersonal information,\u201d \u201cpersonal data,\u201d \u201cpersonally identifiable information\u201d or analogous term as defined in applicable laws (collectively, \u201cPersonal Information\u201d), by or on behalf of the Company, to the Company\u2019s knowledge, the Company is and has been in compliance in all material respects with the following (collectively, \u201cPrivacy Requirements\u201d): (i) all applicable laws governing privacy or data security in all relevant jurisdictions relating to data loss, data theft, and security breach notification obligations, telephone or text message communications, artificial intelligence and automated decision-making, or marketing by email or other channels, (ii) the Company\u2019s published privacy policies, and (iii) the privacy or data security requirements of any contracts, codes of conduct, or industry standards by which the Company is legally bound. \n\nThe Company maintains and has maintained reasonable physical, technical, and administrative security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification, disclosure, and/or other processing. \n\n[To the extent the Company maintains or transmits protected health information, as defined under 45 C.F.R. \u00a7 160.103, as a covered entity or business associate, as defined therein, (i) the Company is in compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 (\u201cHIPAA\u201d), as amended by the Health Information Technology for Economic and Clinical Health Act, including all binding rules and regulations promulgated thereunder and (ii) without limiting the generality of the foregoing, the Company: (A) has designated a privacy official and a security official who is responsible for the development and implementation of the entity\u2019s privacy and security compliance infrastructure; (B) has entered into, and complies with the terms of, business associate agreements as described under HIPAA when required by HIPAA; (C) has provided regular training to its workforce with respect to and to the extent required for compliance with HIPAA; (D) has adopted, and has been in compliance with, privacy and security compliance policies and procedures in compliance with HIPAA; and (E) has completed regular security risk analyses in compliance with HIPAA and has addressed and remediated all material threats, vulnerabilities and deficiencies that have been identified.]\n\n[To the Company\u2019s knowledge, there has been no material unlawful, accidental or unauthorized access to, or destruction, loss, use, modification, disclosure, or other processing of, Personal Information owned, stored, used, maintained or controlled by or on behalf of the Company [where Privacy Requirements obligate the Company to notify government authorities, affected individuals or other parties of such occurrence].]\n\n[Export Control Laws\n\n. The Company has conducted any export transactions in compliance in all material respects with applicable provisions of United States export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, and the export control laws and regulations of any other applicable jurisdiction (collectively, \u201cExport Control Laws\u201d). Without limiting the foregoing: (a) the Company has obtained all required export licenses and other approvals and timely filed any other required filings to the extent required pursuant to Export Control Laws; (b) the Company is in compliance in all material respects with the terms of all applicable export licenses, filing requirements or other approvals; (c) there are no pending or, to the Company\u2019s knowledge, threatened claims or investigations against the Company with respect to Export Control Laws; and (d) [to the Company\u2019s knowledge,] there are no actions, conditions, or circumstances pertaining to the Company\u2019s export transactions that would reasonably be expected to give rise to any material future claims.]\n\n[Healthcare Laws\n\n. The Company is and has been in material compliance with all applicable Healthcare Laws. \u201cHealthcare Laws\u201d means all applicable federal, state, or local health care laws, each as amended, relating to the regulation of the Company, including but not limited to laws regarding fraud and abuse; kickbacks; self-referrals; fee-splitting; the operation of healthcare provider networks or risk bearing entities; beneficiary inducement, false claims, false billing, false coding, reimbursement, and reassignment; record retention; healthcare professional or entity licensure, qualifications, accreditations, or scope of practice requirements, including the practice of telehealth and healthcare professional supervision; the corporate practice of a learned or licensed healthcare profession; health information privacy laws, including those relating to mental health and substance abuse, including [the Health Insurance Portability and Accountability Act of 1996][HIPAA]; and all applicable implementing regulations, rules, ordinances, and orders related to any of the foregoing.]\n\nCFIUS Representations\n\n. The Company does not engage in (a) the design, fabrication, development, testing, production or manufacture of one or more \u201ccritical technologies\u201d within the meaning of", "issue": "This Representations & Warranties requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 26, "snippet": "Section 121.103 of Title 13 of the Code of Federal Regulations (\u201cCFR\u201d)) is a [\u201csmall business concern\u201d][\u201csmaller business\u201d] within the meaning of the "}, {"id": 12, "snippet": "Section 2, and the disclosures in any section of the Disclosure Schedule shall qualify other sections in this Section 2 only to the extent it is readi"}, {"id": 33, "snippet": "Section 3 shall be true and correct in all respects as of the applicable Closing.\n\nPerformance\n\n. The Purchasers purchasing Shares in such Closing sha"}, {"id": 38, "snippet": "Section 2 of the Series [___] Preferred Stock Purchase Agreement, dated as of [date] (the \u201cAgreement\u201d), by and among [Company name] (the \u201cCompany\u201d) an"}]}, {"id": 30, "priority": "Critical", "clause": "Liquidation Preference", "clause_snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities", "full_text": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Company has made no assurances that a public market will ever exist for the Shares.\n\nLegends\n\n. The Purchaser understands that the Shares and any securities issued in respect of or exchange for the Shares, may be notated with one or all of the following legends:\n\n\u201cTHE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.\u201d\n\nAny legend set forth in, or required by, the other Transaction Agreements.\n\nAny legend required by the securities laws of any state to the extent such laws are applicable to the Shares represented by the certificate, instrument, or book entry so legended.\n\nAccredited Investor\n\n. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.\n\nForeign Investors\n\n. If the Purchaser is not a United States person (as defined by", "issue": "This Liquidation Preference requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Show comparables from similar deals in your sector - 1x non-participating is market standard", "Explain that participating preference misaligns incentives - investors profit even from mediocre exits", "Offer to accept 1.5x non-participating as compromise if investor strongly resists", "Calculate and show investor how participating preference reduces their upside in successful exits"], "expected_impact": "Could increase founder payout by $2-5M in typical exit scenarios", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 30, "snippet": "Section 11 of the Securities Act.]\n\nNo Public Market\n\n. The Purchaser understands that no public market now exists for the Shares, and that the Compan"}]}, {"id": 2, "priority": "High", "clause": "General Clause (6 instances found)", "clause_snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be update", "full_text": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to each Purchaser, and each Purchaser shall purchase from the Company, such Purchaser\u2019s Tranche Closing Shares. Exhibit A to this Agreement shall be updated to reflect the number of any Tranche Closing Shares purchased by such Purchaser at the Tranche Closing, if consummated.\n\n[Elective Closings. Each Purchaser may elect to purchase from the Company up to the full number of its Tranche Closing Shares at any time prior to the Tranche Closing, in one or more closings to occur pursuant to this", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Review comparable agreements to identify optimization opportunities", "Focus negotiation energy on higher-priority issues first", "If investor resists, may be acceptable to proceed as-is"], "expected_impact": "Marginal improvement in terms", "risk_level": "Medium", "specific_concerns": [], "detected_terms": ["at any time"], "instances": [{"id": 2, "snippet": "Section 1.2(c)(ii)) in an additional closing on the Tranche Closing Date (the \u201cTranche Closing\u201d). At the Tranche Closing, the Company shall sell to ea"}, {"id": 6, "snippet": "Section 4 of the Restated Certificate), the transferee must agree to receive such Series [__] Preferred Stock subject to the provisions and upon the c"}, {"id": 9, "snippet": "Section\u00a02, the Company shall be deemed to have \u201cknowledge\u201d of a patent right only if the Company has actual knowledge of the patent right.\n\n\u201cKnowledge"}, {"id": 20, "snippet": "Section\u00a02.15.\n\nEmployee Matters\n\n.\n\n[To the Company\u2019s knowledge,] none of its employees is obligated under any contract (including licenses, covenants"}, {"id": 24, "snippet": "Section\u00a02.22, \u201cEnvironmental Laws\u201d means any law, regulation, or other applicable requirement relating to (a) releases or threatened release of Hazard"}, {"id": 25, "snippet": "Section 1202(e)(4) of the Code, (ii) the Company will not have made purchases of its own stock described in Code Section 1202(c)(3)(B) during the one-"}]}, {"id": 16, "priority": "High", "clause": "Vesting", "clause_snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (", "full_text": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary vesting schedule either (x) as to employees, [monthly] over four years with a one-year cliff, or (y) as to consultants, [monthly] over [___] months. (ii) Except as described in Section 2.2(d)(ii) of the Disclosure Schedule, none of the Company\u2019s stock purchase agreements or stock option documents contains a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions or other terms of such agreement or understanding upon the occurrence of any event or combination of events, including, without limitation, in the case where the Company\u2019s Stock Plan is not assumed in an acquisition. (iii) The Company has never adjusted or amended the exercise price of any stock options previously awarded, whether through amendment, cancellation, replacement grant, repricing, or any other means. (iv) Except as set forth in the Restated Certificate, the Company has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. \n\nThe Company has obtained valid waivers of any rights by other parties to purchase any of the Shares covered by this Agreement. \n\nSubsidiaries\n\n. The Company does not currently own or control, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, limited liability company, association, or other business entity (each, a \u201csubsidiary\u201d).  To the extent the Company has one or more subsidiaries, each subsidiary is wholly owned by the Company. The Company is not a participant in any joint venture, partnership or similar arrangement.\n\nAuthorization\n\n. All corporate action required to be taken by the Board of Directors and the Company\u2019s stockholders in order to authorize the Company to enter into the Transaction Agreements, and to issue the Shares at the [applicable] Closing and the Common Stock issuable upon conversion of the Shares, has been taken[ or will be taken prior to the [applicable] Closing]. All action on the part of the officers of the Company necessary for the execution and delivery of the Transaction Agreements, the performance of all obligations of the Company under the Transaction Agreements to be performed as of the [applicable] Closing, and the issuance and delivery of the Shares has been taken[ or will be taken prior to the [applicable] Closing]. The Transaction Agreements, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms except (i)\u00a0as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors\u2019 rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; or (iii)\u00a0to the extent the indemnification provisions contained in the Investors\u2019 Rights Agreement and the Indemnification Agreement may be limited by applicable federal or state securities laws.\n\nValid Issuance of Shares\n\n. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable and free of restrictions on transfer other than restrictions on transfer under the Transaction Agreements, applicable state and federal securities laws and liens or encumbrances created by or imposed by a Purchaser. Assuming the accuracy of the representations of the Purchasers in", "issue": "This Vesting requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Request at least 25% immediate acceleration on acquisition", "Add acceleration if title, role, or compensation changes post-acquisition", "Include that vesting continues during short-term disability"], "expected_impact": "Provides protection worth $200K-$1M in acquisition scenarios", "risk_level": "Medium", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 16, "snippet": "Section 2.2(d)(i) of the Disclosure Schedule, all outstanding Common Stock and all stock options held by service providers are subject to a customary "}]}], "startup_type": "fintech", "summary": {"total": 38, "high": 18, "medium": 19, "low": 1}, "metadata": {"startupType": "fintech", "fundingStage": "seed"}, "analysis_id": "20251202_034346", "filename": "NVCA-Model-SPA-10-28-2025.docx"}, "20251202_034746": {"success": true, "analysis_timestamp": "2025-12-02T03:47:50.199916", "document_info": {"filename": "20251202_034746_Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx", "page_count": 0, "word_count": 500}, "clauses": [{"id": 1, "type": "General Clause", "text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "position": 36, "entities": [{"text": "Post-Money Valuation Cap", "label": "ORG", "start": 204, "end": 228}, {"text": "Investor Name", "label": "PLACEHOLDER", "start": 0, "end": 0}, {"text": "Company Name", "label": "PLACEHOLDER", "start": 0, "end": 0}], "key_terms": [], "title": "Paragraph 3", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 5, "type": "General Clause", "text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "full_text": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered.", "position": 2976, "entities": [], "key_terms": [], "title": "Paragraph 7", "risk_level": "Medium", "confidence": 0.7, "explanation": "This General Clause clause is fairly standard but requires careful consideration.", "detection_method": "rule_based", "detected_issues": [], "specific_terms": []}], "risk_assessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "riskAssessment": {"overall_score": 18.0, "overall_level": "High", "risk_distribution": {"High": 4, "Medium": 1, "Low": 0}, "clause_count": 5, "dangerous_clauses": [{"type": "General Clause", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Voting Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}, {"type": "Pro-Rata Rights", "risk_level": "High", "risk_score": 0, "concern": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition."}], "clause_types": {"General Clause": {"count": 2, "risk_levels": {"High": 1, "Medium": 1, "Low": 0}}, "Pro-Rata Rights": {"count": 2, "risk_levels": {"High": 2, "Medium": 0, "Low": 0}}, "Voting Rights": {"count": 1, "risk_levels": {"High": 1, "Medium": 0, "Low": 0}}}, "red_flags": 4, "risk_categories": {"operational": {"count": 1, "severity": "High", "clauses": [{"id": 3, "type": "Voting Rights", "text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "position": 1223, "entities": [{"text": "Company", "label": "ORG", "start": 159, "end": 166}, {"text": "Company", "label": "ORG", "start": 270, "end": 277}, {"text": "one", "label": "CARDINAL", "start": 608, "end": 611}], "key_terms": [], "title": "Paragraph 5", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}, "regulatory": {"count": 0, "severity": "Low", "clauses": []}, "financial": {"count": 2, "severity": "High", "clauses": [{"id": 2, "type": "Pro-Rata Rights", "text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "position": 583, "entities": [{"text": "Standard Preferred Stock", "label": "ORG", "start": 68, "end": 92}, {"text": "the Equity Financing", "label": "ORG", "start": 107, "end": 127}, {"text": "Capital Stock", "label": "ORG", "start": 248, "end": 261}, {"text": "Post-Money Valuation Cap", "label": "ORG", "start": 328, "end": 352}, {"text": "the Company Capitalization", "label": "ORG", "start": 361, "end": 387}, {"text": "the Equity Financing", "label": "ORG", "start": 502, "end": 522}, {"text": "a Liquidity Event", "label": "ORG", "start": 565, "end": 582}, {"text": "the Dissolution Event", "label": "ORG", "start": 614, "end": 635}], "key_terms": [], "title": "Paragraph 4", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}, {"id": 4, "type": "Pro-Rata Rights", "text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "full_text": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of shares of Capital Stock issued from all Safes converted in connection with the Equity Financing held by the Investor and other Safe holders with Pro Rata Rights pursuant to agreements on the same form as this Agreement (available at http://ycombinator.com/documents), provided that such amendment, waiver or modification treats all such holders in the same manner, or (ii) the Investor.  The Company will promptly notify the Investor of any amendment, waiver or modification that the Investor did not consent to.  This Agreement is the form available at http://ycombinator.com/documents and the Company and the Investor agree that neither one has modified the form, except to fill in blanks and bracketed terms.  The choice of law governing any dispute or claim arising out of or in connection with this Agreement shall be consistent with that set forth in the Investor\u2019s Safe.", "position": 1945, "entities": [{"text": "Company", "label": "ORG", "start": 99, "end": 106}, {"text": "Capital Stock", "label": "ORG", "start": 161, "end": 174}, {"text": "the Equity Financing", "label": "ORG", "start": 226, "end": 246}, {"text": "Pro Rata Rights", "label": "ORG", "start": 296, "end": 311}, {"text": "Company", "label": "ORG", "start": 746, "end": 753}], "key_terms": [], "title": "Paragraph 6", "risk_level": "High", "confidence": 0.9, "explanation": "CRITICAL: This vesting clause contains NO acceleration provisions. If the company is acquired or you're terminated, you forfeit all unvested shares. In a typical 4-year vest, if acquired after 2 years, you lose 50% of your equity - potentially millions of dollars. Founders should always have at least single-trigger acceleration on acquisition.", "detection_method": "content_analysis", "detected_issues": ["No acceleration clause - lose equity in acquisition", "Founder could lose millions in exit"], "specific_terms": []}]}}, "summary": "\u2713 Low Risk: Agreement appears founder-friendly with standard market terms."}, "future_predictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "futurePredictions": {"timeline": [{"period": "6-12 months", "risks": [{"title": "Cash Flow Restrictions", "probability": 65, "impact": "Medium", "description": "Information rights may evolve into investor micromanagement of expenses and burn rate."}]}, {"period": "1-2 years", "risks": [{"title": "Fundraising Blocked", "probability": 60, "impact": "High", "description": "Drag-along and board control give investors power to block future fundraising if they disagree with terms."}]}], "overall_outlook": {"probability": 62, "sentiment": "Concerning", "summary": "This agreement contains several concerning terms. Historical data from fintech startups shows 62% probability of founder-unfavorable outcomes."}}, "recommendations": [{"id": 1, "priority": "Critical", "clause": "General Clause (2 instances found)", "clause_snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or", "full_text": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of that certain simple agreement for future equity with a \u201cPost-Money Valuation Cap\u201d (the \u201cInvestor\u2019s Safe\u201d) issued by [Company Name] (the \u201cCompany\u201d) on or about the date of this Agreement.  As a material inducement to the Investor\u2019s investment, the Company agrees to the provisions set forth in this Agreement.  Capitalized terms used herein shall have the meanings set forth in the Investor\u2019s Safe.", "issue": "This General Clause requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 1, "snippet": "This agreement (this \u201cAgreement\u201d) is entered into on or about [Date of Safe] in connection with the purchase by [Investor Name] (the \u201cInvestor\u201d) of th"}, {"id": 5, "snippet": "IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered."}]}, {"id": 2, "priority": "Critical", "clause": "Pro-Rata Rights (2 instances found)", "clause_snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of t", "full_text": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d).  Pro rata share for purposes of this Pro Rata Right is the ratio of (x) the number of shares of Capital Stock issued from the conversion of all of the Investor\u2019s Safes with a \u201cPost-Money Valuation Cap\u201d to (y) the Company Capitalization.  The Pro Rata Right described above shall automatically terminate upon the earlier of (i) the initial closing of the Equity Financing; (ii) immediately prior to the closing of a Liquidity Event; or (iii) immediately prior to the Dissolution Event.", "issue": "This Pro-Rata Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Research market standards for this clause type in your industry", "Consult with legal advisor on specific risks", "Request modifications that align with standard practices", "Consider proposing alternative language that addresses investor concerns while protecting founders"], "expected_impact": "Reduces risk and improves founder protections", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 2, "snippet": "The Investor shall have the right to purchase its pro rata share of Standard Preferred Stock being sold in the Equity Financing (the \u201cPro Rata Right\u201d)"}, {"id": 4, "snippet": "Any provision of this Agreement may be amended, waived or modified upon the written consent of the Company and either (i) the holders of a majority of"}]}, {"id": 3, "priority": "Critical", "clause": "Voting Rights", "clause_snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Inves", "full_text": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consent of the Company; provided, however, that this Agreement and/or the rights contained herein may be assigned without the Company\u2019s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor.", "issue": "This Voting Rights requires review", "recommendation": "Consult legal advisor", "negotiation_tips": ["Agree to veto on major items but remove from operational decisions", "Define clear thresholds (e.g., only transactions >$X need approval)", "Add that veto rights expire if investor doesn't participate in future rounds", "Include that unreasonable withholding of consent allows founders to proceed"], "expected_impact": "Maintains day-to-day operational freedom", "risk_level": "High", "specific_concerns": [], "detected_terms": [], "instances": [{"id": 3, "snippet": "Neither this Agreement nor the rights contained herein may be assigned, by operation of law or otherwise, by Investor without the prior written consen"}]}], "startup_type": "fintech", "summary": {"total": 5, "high": 4, "medium": 1, "low": 0}, "metadata": {"startupType": "fintech", "fundingStage": "seed"}, "analysis_id": "20251202_034746", "filename": "Pro Rata Side Letter-d6dd8d827741862b18fba0f658da17fb4e787e5f2dda49584b9caea89bf42302.docx"}}